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ABSTRACT 
 
During pregnancy, uterine and placental blood vessels develop to facilitate 
maximal transfer of nutrients to the fetus. These studies focus on the incorporation of 
endothelial progenitor cells (EPCs) into the growing placental and uterine vasculatures 
(Study 1), and on the expression of the sodium-dependent glucose transporter (SLC5A1) 
and amino acid transporter (SLC7A3) in uterine and placental tissues (Study 2). For 
Study 1, RT-PCR indicated that purified monocytes isolated from newborn piglets 
differentiated into an endothelial-like phenotype in culture. While human umbilical vein 
endothelial cells (HUVECs) alone invaded a 3D collagen model to form multicellular 
tubes with lumens and branching structures, EPCs alone did not invade the matrices. 
However, when cultured in the presence of HUVECs, EPCs incorporated into vascular 
structures. Osteopontin (OPN) is a matricellular molecule highly expressed in regions of 
angiogenesis within the pig placenta. When HUVECs and EPCs were cultured in the 
presence of OPN, the number of EPCs that incorporated into newly-forming HUVEC 
sprouts increased significantly. EPCs express integrins, which act as transmembrane 
receptors for OPN. Affinity chromatography followed by immunoprecipitation studies 
suggested that the ITGAV subunit on EPCs directly bound OPN. Knocking down the 
ITGAV subunit using siRNA significantly decreased the ability of EPCs to adhere to 
OPN-coated culture wells in adhesion assays. For Study 2, in situ hybridization and 
qPCR revealed that SLC5A1 mRNA expression in uterine luminal (LE) and peaked on 
Day 12-13 of pregnancy. in situ hybridization analysis confirmed that SLC5A1 
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expression increased specifically in LE of pseudopregnant model and qPCR revealed 
that estrogen increased SLC5A1 mRNA (P<0.05) in vivo and in vitro. SLC7A3 was 
induced in the chorion between Days 25 and 30. qPCR confirmed a significant increase 
in SLC7A3 mRNA in Day 60 as compared to Day 30 placentae. In conclusion, we 
hypothesize: (1) that OPN binds to ITGAV-containing integrins on EPCs as an essential 
initial step in EPC incorporation into the growing vasculature to maximize placental 
vascularization; and (2) that SLC5A1 is increased in uterine LE of pigs by estrogens to 
mediate glucose transport, while SLC7A3 may mediate arginine transport across the 
placenta to support developing fetuses in pigs. 
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NOMENCLATURE 
 
CAT   Cationic Amino Acid Transporter 
DMEM  Dulbecco's Modified Eagle Medium 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
EPC   Endothelial Progenitor Cell 
FGF   Fibroblast Growth Factor 
GE/LE   Glandular Epithelium/ Luminal Epithelium 
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siRNA   Small Interfering RNA 
SGLT   Sodium-dependent Glucose Transporter  
TPA   12-O-tetradecanoylphorbol-13-acetate  
Tr   Trophectoderm 
VE-CAD  Vascular Endothelia Cadherin 
VEGF   Vascular Endothelial Growth Factor 
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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
 
Porcine Uterine and Placental Structure 
Uterine Structure  
The uterine wall in pigs differentiates embryologically from the Mullerian ducts 
into endometrial and myometrial compartments (Mossman 1987). The endometrium 
consists of a luminal epithelial (LE) layer, secretory glandular epithelial (GE) cells lining 
the coiling, branching endometrial glands, immune cells, vasculature, and stromal 
fibroblasts that are spatially arranged into a loose stratum spongiosum and dense stratum 
compactum (Friess, et al. 1981, Friess, et al. 1982). The myometrium is composed of 
inner circular and outer longitudinal smooth muscle layers, and vascular elements 
(Cooke, et al. 1998). Autocrine, paracrine and endocrine communication among these 
cell types mediate: complex responses to increased uterine blood flow (Ford, et al. 1982); 
production of and responses to cytokines (Geisert, et al. 1982); changes in water and 
electrolyte movement (Veldius, et al. 1980); development of and responses to the 
maternal recognition of pregnancy (Bazer and Thatcher 1977); uterine receptivity to 
conceptus attachment for implantation (Burghardt, et al. 1997, Keys and King 1980); 
and uterine secretory activity (Roberts, et al. 1993). 
Successful establishment and maintenance of pregnancy requires coordinated 
communication between the uterus and the conceptus including: (1) secretions from the 
conceptus to signal pregnancy recognition (Spencer and Bazer 2002) (2) secretions from 
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the uterine luminal epithelium (LE) and glandular epithelium (GE) i.e., histotroph, to 
support attachment, development and growth of the conceptus (Ashworth and Bazer 
1989, Burton, et al. 2002, Gray, et al. 2001). (3) remodeling at the endometrial LE 
surface to allow intimate association between conceptus trophectoderm and 
endometrium for implantation (Denker 1993, Glasser and Mulholland 1993) and (4) 
remodeling of the endometrial stroma to generate a cytokine-rich environment that 
promotes angiogenesis that provides hematotrophic support for the developing conceptus 
(Dosiou and Giudice 2005, Kliman 2000). 
 
Conceptus Elongation  
In pigs (Bazer, et al. 2005), the 1-cell fertilized ovum or zygote undergoes 
cleavage to form a 2-cell embryo by 26 h after fertilization. Embryos remain in the 
oviduct before entering the uterus at 48 to 56 h. Blastocyst formation is a critical stage in 
early embryonic development when cells segregate into the trophectoderm (Tr), 
embryonic disc, extra-embryonic endoderm and blastocoel necessary for continued 
development and differentiation to a conceptus. Before blastocysts develop into a 
conceptus, they hatch from the zona pellucida. Pig embryos are 0.5 to 1 mm diameter 
spheres at this stage, and they increase in size through Day 10 of pregnancy (2-6 mm) 
before undergoing a morphological transition to larger spheres of 10 to 15 mm diameter 
and then tubular (15 mm by 50mm) and filamentous (l mm by 100-200 mm) forms by 
Day 11. Pig conceptuses elongate at 30 to 45 mm/h during the transition from tubular to 
filamentous forms, primarily by cellular remodeling of trophectoderm. Porcine 
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conceptuses subsequently grow to 800 to 1000 mm in length by Day 15 of pregnancy 
(Bazer 1975). The period of rapid elongation of pig conceptuses is accompanied by 
estrogen production by Tr (Bazer and Thatcher 1977) along with interferons gamma 
(IFNG) and delta (IFND) (La Bonnardière, et al. 1991, Lefèvre, et al. 1998).  
 
Maternal Recognition of Pregnancy 
The initial conceptus signal to instruct the mother that it is necessary to create an 
optimal environment for conceptus elongation, implantation and placentation is known 
as the pregnancy recognition signal. The pregnancy recognition signal in pigs is estrogen, 
which is secreted by elongating conceptuses on Days 11 and 12 of pregnancy (Bazer 
1975, Geisert, et al. 1982, Spencer and Bazer 2004). The importance of estrogen to 
implantation of pig conceptuses is underscored by the fact that premature exposure of 
the pregnant uterus to estrogen on Days 9 and 10 results in degeneration of all pig 
conceptuses by Day 15 (Ashworth, et al. 2006). Estrogen redirects prostaglandin F2α 
(PGF) secretion from the uterine vasculature to the uterine lumen, where it is 
metabolized and thereby sequestered away from the corpora lutea (Bazer and Thatcher 
1977, Frank, et al. 1977, Spencer, et al. 2004). This ensures continued production of 
progesterone, which is required for pregnancy (Bazer 2013). In addition to serving as a 
pregnancy recognition signal, conceptus estrogens modulate uterine gene expression 
responsible for endometrial remodeling from Days 13 through 25 of gestation required 
for implantation (Geisert, et al. 1982) and also correlate with conceptus secretion of 
interleukin-1 beta, which may be a uterine response to this cytokine (Ross, et al. 2003). 
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Successful establishment and maintenance of pregnancy requires coordinated 
communication between the uterus and the conceptus including: (1) secretions from the 
conceptus to signal pregnancy recognition (Spencer and Bazer 2002) (2) secretions from 
the uterine luminal epithelium (LE) and glandular epithelium (GE) i.e., histotroph, to 
support attachment, development and growth of the conceptus; (3) remodeling at the 
endometrial LE surface to allow intimate association between conceptus trophectoderm 
and endometrium for implantation (Denker 1993, Glasser and Mulholland 1993) and (4) 
remodeling of the endometrial stroma to generate a cytokine-rich environment that 
promotes angiogenesis that provides hematotrophic support for the developing conceptus 
(Dosiou and Giudice 2005, Kliman 2000). 
 
Implantation 
Implantation is the process by which the blastocyst attaches to the wall of the 
uterus for juxtaposition of embryonic and maternal circulations leading to the 
establishment of a functional placenta and successful pregnancy. In pigs, the process is 
characterized by a lengthy pre-attachment period that includes blastocyst hatching from 
the zona pellucida and a morphological transition to filamentous conceptus through Days 
10 and 12, as well as embryonic migration to produce even spacing within the uterus 
(Bazer 1975). Attachment of Tr to LE is fully established by Days 12 and 15 of 
pregnancy (Bazer, et al. 2012b). During the peri-implantation period of pregnancy, LE 
cells and conceptus trophectoderm becomes adhesion competent in synchrony to initiate 
an adhesion cascade within a limited period of time in the uterine wall cycle termed the 
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“window of receptivity.” These cells demonstrate bi-directional interactions (between 
the blastocyst and uterine endometrium) involving spatiotemporally regulated endocrine, 
paracrine and autocrine signals that mediate cell-cell and cell-matrix interactions (Burton, 
et al. 2002, Choi, et al. 2001, Denker 1993, Hicks, et al. 2003, Lefèvre, et al. 1988, Ott, 
et al. 1998, Spencer, et al. 2007) 
Uterine endometrial responses to implantation are complex. In addition to 
remodeling of the uterine LE (Aboagye-Mathiesen, et al. 1995), both LE and GE secrete 
histotroph to nourish and support development of the conceptus (Bebington, et al. 1999). 
One component of histotroph is osteopontin (OPN), a versatile extracellular matrix 
protein induced by estrogen in LE where it is hypothesized to influence trophectoderm 
and LE adhesion, signal transduction and cell migration (White, et al. 2005). Uterine 
stromal cell responses include cellular transformation to prevent/control movement of 
the conceptus through the uterine wall during implantation while generating a cytokine-
rich environment that directly promotes angiogenesis to ensure sufficient blood flow to 
the placenta for hematotrophic nourishment of fetal development (Austin, et al. 2003, 
Bany and Cross 2006, Li, et al. 2001). 
 
Placental Development 
A major function of the placenta is the exchange of gases, micronutrients 
(including amino acids, glucose) and macromolecules (proteins), as well as the 
production of hormones, cytokines and other molecules that regulate development of the 
conceptus throughout gestation (Flint, et al. 1982). In all mammals, the process begins 
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with attachment of conceptus Tr to the LE (Bazer and First 1983, Joyce, et al. 2008). 
After successful implantation, the allantois develops outward from the embryo to 
establish the allantochorion, which determines the size of the functional placenta 
(Geisert, et al. 1982, Mayhew, et al. 2004, Vallet, et al. 2009). Chorionic trophoblasts 
adhere to endometrial epithelial cells and the broad extent of the placenta is facilitated 
by retention of a large allantoic sac. Ultrastructural analyses of the fetal-placental 
interface have identified interdigitations of microvilli along the surface of the trophoblast 
and uterine epithelium (Carter and Enders 2013). Pigs have a non-invasive, 
epitheliochorial placentation as attachment of conceptus to the endometrium remains 
superficial, and all three maternal and three embryonic cellular layers separating the 
maternal from fetal circulations remain intact (Friess, et al. 1981, Wooding 1992). 
Extensive remodeling to form chorionic (placental) ridges and corresponding 
endometrial intussusception results in folding that maximizes the area of uterine-
placental interface. Indentation of the LE and Tr by underlying capillaries further 
reduces the distance between maternal and fetal blood, providing a short diffusion 
distance across the placenta (Flint, et al. 1982). This is possibly an advantage for long 
pregnancies in large animals. It has been debated as to whether this more recently 
evolved placenta is a more efficient strategy; however, epitheliochorial placentation is 
optimized to prevent uterine infection or diseases and protects the fetus from the 
maternal immune system as compared to hemochorial placentas that favor nutrient 
transport to the fetus through invasion of placental tissues into the uterine wall (Carter 
and Enders 2013, Huxley 1880, Moffett and Loke 2006, Mossman 1987). The 
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interdigitation of microvilli between Tr and LE eventually covers the entire placenta 
except at the openings of uterine glands, where Tr does not attach to LE. These unique, 
dome-shaped, placental pockets called areolae develop to take up secreted products from 
endometrial glands that contribute to histotroph that contains proteins, hormones and 
other nutrients that support fetal growth. A number of the secretory products of the 
glands including uteroferrin are progesterone-dependent in the pig (Fazleabas, et al. 
1985, Simmen, et al. 1991). The transfer of histotroph along with selected molecules 
from maternal serum may occur by either simple or facilitated diffusion or active 
transport across the areolae of the chorioallantoic placenta by fluid phase pinocytosis for 
release into the fetal circulation (Ashworth, et al. 2006, Geisert, et al. 1982). The 
placenta of each piglet in a litter contains approximately 2,500 areolae and this number 
is correlated with fetal weight (White, et al. 2005). The fetal nutritional environment 
regulates circulating levels of important fetal growth factors from the maternal blood to 
support fetal growth while fetal glucose metabolism is determined by additive effects of 
fetal plasma glucose and insulin (Bloomfield, et al. 2013b, Hay 2006) Fetal growth and 
development depends on a maternal supply of nutrients through placental exchange, 
despite the fact that placenta is a low permeability barrier to nutrient transfer (Smith, et 
al. 1992). However, transport of the main extracellular ions, such as Na+ and Cl-, 
depends less on diffusion and the transfer rates are consistent with passive transfer (Stulc 
1997). 
 
 
 8 
 
Angiogenesis During Pregnancy 
Vasculogenesis is the formation of blood vessels in place by the aggregation of 
angioblasts into a cord, and is representative of fetal vasculogenesis (Risau, et al. 1988). 
Postnatal neovascularization is a series of physiological events including proliferation, 
migration, and remodeling of fully differentiated endothelial cells derived from 
preexisting blood vessels (Folkman and Shing 1992). In contrast to fetal vasculogenesis, 
angiogenesis is the formation of new vessels by the sprouting of capillaries from existing 
vessels (Poole and Coffin 1989). Such development of new capillaries from pre-existing 
vessels is usually initiated by growth factors, such as bFGF, VEGF, or placental growth 
factor (PlGF) to initiate mitogenic activation of endothelial cells, induction of serine 
proteases and collagenases, and increase endothelial chemotaxis and vasodilation 
(Kaufmann, et al. 2004, Sherer and Abulafia 2001). Pro- and anti-angiogenic factors can 
directly bind integrin receptors as well to regulate endothelial cell behavior. During 
angiogenesis, autocrine and paracrine growth pathways regulate integrins on the 
endothelial surface via tyrosine kinase receptors (Serini, et al. 2008). 
The female reproductive system (i.e., ovary, uterus, and placenta) exhibits 
dynamic, periodic growth and regression in addition to changes in blood flow over the 
course of each menstrual cycle and over the extent of pregnancy. During gestation, 
disturbances in uterine blood supply increase risk of perinatal morbidity and mortality 
caused by preeclampsia, preterm delivery or intrauterine growth restriction. Many 
diseases such as dysfunctional uterine bleeding, endometriosis, endometrial hyperplasia 
and/or cancer result from endothelial cell malfunction or remodeling errors due to 
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deficits or alterations in the expression of angiogenic factors (Zygmunt, et al. 2003). 
Growth factors are the major regulatory contributors to these physiological events. For 
example, VEGF and angiopoietin-1 and -2 appear to play major roles in ovarian 
angiogenesis (Ferrara and Davis-Smyth 1997, Findlay 1986, Jaffe 2000, Reynolds, et al. 
1992). An adequate nutrient supply supported by neovascularization is essential for 
normal fetal development. There is an intimate correlation between the increase of blood 
flow of the placenta and angiogenesis (Reynolds, et al. 2006). It is clear that 
neovascularization is critical to conceptus development in all species for maternal-fetal 
nutrient exchange. Human hemochorial placentation is rich in angiogenic substances that 
regulate placental vessel formation as well as control maternal vascular adaptation (i.e. 
vasodilation and vascular permeability) to pregnancy (Zygmunt, et al. 2003). This is also 
true in porcine epitheliochorial placentation where both uterine and placental layers of 
epithelium remain intact. For adequate nutrient exchange from maternal to placental 
vasculatures to be maintained, a tremendous amount of angiogenesis in the uterus and 
placenta is required (Bazer, et al. 2012b, Sanchis, et al. 2011). Novel in vitro culture 
methods have been used to study angiogenesis. One such system utilizes serum-free 
media to evaluate capillary morphogenesis during human endothelial cell (EC) invasion 
of three-dimensional collagen matrices (Davis, et al. 2000). In this model, ECs invade 
these matrices over a 1–3 day period to form capillary tubes. Improvements in this 
model system have been useful for elucidating intracellular mechanisms for pro-
angiogenic factors that regulate sprout formation. In this improved protocol, endothelial 
cells are seeded on prepared three-dimensional collagen matrices and rapid invasion into 
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collagen matrices is driven by sphingosine 1-phosphate (S1P) and growth factors (bFGF 
and VEGF); endothelial sprouting responses can be quantified and imaged after 24 h 
(Bayless, et al. 2009). S1P acts through G-protein-coupled receptors (GPCR) to inhibit 
the Hippo pathway kinases Lats1/2, resulting in stimulation of actin polymerization, and 
in activation of YAP and TAZ transcription activators, which are oncoproteins repressed 
by Lats1/2. Hippo pathway may regulate organ size in a tissue-specific manner, but 
further studies are needed to address these important biological issues. YAP and TAZ 
are involved S1P-induced gene expression. The pathway may explain endothelial cell 
and possibly progenitor cell regulation of proliferation and migration to the presence of 
S1P (Yu, et al. 2012). 
 
Endothelial Progenitor Cells 
Endothelial progenitor cells (EPCs) are circulating monocytes that not only 
express cell surface markers that are similar to those expressed by vascular endothelial 
cells, but also adhere to endothelium at sites of hypoxia/ischemia. Postnatal bone 
marrow is known to contain these progenitor cells, and the recruitment of EPCs from the 
bone marrow into the circulation involves the activation of matrix metalloproteinase-9 
(MMP-9), which promotes the transformation of membrane bound Kit-ligand to a 
soluble Kit-ligand, permitting the transfer of endothelial and hematopoietic stem cells 
(HSCs) from the quiescent to a proliferative form (Heissig, et al. 2002). EPCs are 
present in peripheral blood and can proliferate, differentiate, migrate in situ and 
contribute to the process of neovascularization (Asahara 1997). EPCs are characterized 
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by the expression of cell surface markers, the three most accepted being CD34+, CD133 
and the vascular endothelial growth factor receptor-2 (Hristov, et al. 2003). The marker 
set (CD133+/CD34+/VEGFR-2+/CD14-) represents a small population of progenitor 
cells with proliferative potential in the circulation, capable of giving rise to late 
endothelial outgrowth. Cultured EPCs exhibit upregulation of monocyte activation and 
macrophage differentiation markers (Gulati, et al. 2003, Rehman, et al. 2003). They do 
not proliferate but secrete potent proangiogenic growth factors (i.e., hepatocyte growth 
factor, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-
stimulating factor) (Hristov and Weber 2004). An important regulator of this EPC 
mobilization is VEGF, which binds to its receptor VEGFR-2 to mediate further 
maturation of the cells via the cascade of hemangioblast–angioblast–early EPC–late EPC 
axis (Hristov, et al. 2003, Hristov and Weber 2004). Recruitment and incorporation of 
EPCs into sites of neovascularization is a coordinated multistep process including 
chemoattraction, adhesion, endothelial transmigration, EPC migration, tissue invasion 
and paracrine factor production (Fusenig and Marmé 2008). 
These cells have been isolated and purified from the blood of adult mice, and 
have been shown to differentiate into endothelial cells in vitro (Asahara, et al. 1999). 
One such method is to isolated monocytes from the blood and then select the progenitor 
population through selection by outgrowth on fibronectin during in vitro culture 
(Asahara 1997). The resulting cells have been used extensively to determine functional 
significance. EPC’s can mature into the cells that line the lumen of blood vessels (Luttun, 
et al. 2002, Luttun and Carmeliet 2003). They are important in tumor growth and are 
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critical for metastasis and angiogenesis (Gao, et al. 2009). Inflammation is an angiogenic 
process; and the number and function of circulating EPCs changes in many pathological 
conditions involving inflammation including atherosclerosis, diabetes, and after 
myocardial infarction. Increased circulating EPCs may account for systemic 
inflammation along with upregulated levels of growth factors in patients with unstable 
angina syndromes and no evidence of cardiac necrosis (George, et al. 2004). The 
functional capabilities of EPCs, such as adhesion to extracellular matrix or migration in 
response to cytokines, may be as important as the circulating number of cells (Hristov, et 
al. 2003). Scleroderma patients have a marked reduction in EPCs in the circulation 
compared with normal healthy controls (Gomer 2008). Improved methods are being 
developed to quantify EPCs in order to better analyze their role in normal developmental 
processes as well as vasculopathy (Kuwana and Okazaki 2012, Kuwana, et al. 2004). 
The number of EPCs increase during healthy pregnancy and decrease with 
gestational diabetes (Buemi, et al. 2007). EPC proliferation and number are altered in 
preeclampsia patients (Matsubara, et al. 2006). In diseases such as endometriosis, up to 
37% of the microvascular endothelium of the ectopic endometrial tissue originates from 
EPCs (Laschke, et al. 2011). Indeed, some recent studies linking EPCs to pregnancy 
have been published.  
 
Osteopontin and Integrins During Pregnancy 
Although originally identified in bone osteoblasts and osteoclasts, hence the 
prefix “osteo”, OPN expression is found in a number of different tissues in many species 
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that exhibit multiple biological regulatory functions. Similar to in other physiological 
systems, OPN has been shown to exert multiple functions during pregnancy in mammals 
(Apparao, et al. 2003, Apparao, et al. 2001, Denhardt and Guo 1993, Johnson, et al. 
2003, Liaw, et al. 1995a, Liaw, et al. 1995b, von Wolff, et al. 2001). This matricellular 
protein is a negatively-charged phosphorylated glycoprotein ligand for several members 
of the integrin family via an arginine-glycine-aspartic acid (RGD) cell adhesion 
sequence (Johnson, et al. 2003). Therefore, it can serve as an attachment substrate or 
linking protein connecting several cell types and hence the suffix "-pontin" (derived 
from "pons," the Latin word for bridge) (Somerman, et al. 1989). OPN is also known as 
a marker for the metastatic potential of various cancers as it increases matrix 
metalloproteases (MMPs) activity along with cell motility, invasion, and angiogenesis 
(Rangaswami, et al. 2006). In addition, OPN is chemotactic for neutrophils, and this is 
why OPN plays an important role in many diseases such as neutrophil recruitment in 
alcoholic liver disease (Apte, et al. 2005, Banerjee, et al. 2006). Integrins are capable of 
binding to RGD and non-RGD peptide sequences to activate cell signaling pathways. 
OPN interacts with ITGA4B1 (α4β1) and ITGA9B1 (α9β1) integrin receptors via non-
RGD integrin recognition sequences, and interacts several other integrin receptors 
including ITGA5B1 (α5β1) and ITGAVB1 (αvβ1), ITGAVB3 (αvβ3), ITGAVB5 (αvβ5), 
ITGAVB6 (αvβ6), ITGAVB8 (αvβ8) and ITGA8B1 (α8β1) via its RGD domain (Johnson, 
et al. 2003).  
Most cells adhere to OPN via the ITGAVB3 and ITGAVB5 which are integrins 
known to activate tumor-induced angiogenesis (Hu, et al. 1995b, Liaw, et al. 1995b, 
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Somerman, et al. 1989). Integrins binding to the RGD site are known to enhance cell 
adhesion (Hu, et al. 1995a, Liaw, et al. 1994, Ross, et al. 1993), but the potential 
physiological role of integrins binding to non-RGD sites are not fully understood 
(Katagiri, et al. 1996, Nasu, et al. 1995, Smith, et al. 1996, Van Dijk, et al. 1993). In pigs, 
OPN mRNA and protein are expressed in the luminal and glandular epithelium of the 
endometrium as well as in select mesenchymal cells within the stroma of both the 
placenta and uterus, although the temporal and spatial expression may vary slightly 
between different breeds such as Meishans and Large Whites (Garlow, et al. 2002, 
Hernandez, et al. 2013, White, et al. 2005). OPN expression has been correlated with 
litter size, conceptus growth and has been reported to improve development of porcine 
embryos in vitro (Garlow, et al. 2002, Hao, et al. 2008, Korwin-Kossakowska, et al. 
2001). There is considerable literature supporting the physiological role of OPN in 
embryo implantation, placentation, and placental development (Garlow, et al. 2002, 
Johnson, et al. 2003, Johnson, et al. 1999a, Johnson, et al. 1999b, Nomura, et al. 1988, 
White, et al. 2005). In sheep, progesterone and interferon-tau (the pregnancy recognition 
signal) induce expression, secretion and proteolytic cleavage of OPN by uterine 
epithelium (Bailey, et al. 2010, Garlow, et al. 2002, Johnson, et al. 1999b, White, et al. 
2005). Additionally in a mouse model, OPN and ITGB3 (the β3 integrin subunit) are co-
expressed and are used as biological markers for endometrial receptivity because both 
play critical roles in blastocyst implantation (Liu, et al. 2013). In humans, OPN was 
found to be associated with endometrial maturation (Bhagwat, et al. 2013) and is 
upregulated during the receptive phase of the uterus as well (Bhagwat, et al. 2013). 
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 Integrins are heterodimeric transmembrane receptors consisting of non-
covalently linked α (alpha) and β (beta) chains that are capable of binding extracellular 
matrix and counter receptors on cells. More than one integrin receptor can recognize a 
specific ligand and more than one ligand can bind a specific integrin receptor 
(Humphries 2006). The receptor dimer is largely extracellular; and both subunits 
terminate in short cytoplasmic domains. There are 19 alpha and 8 beta subunit genes in 
mammals that can form 25 different receptors (Campbell and Humphries 2011, 
Humphries 2006, Humphries 2000). Integrins were first identified as integral, 
transmembrane protein complexes which mediate divalent cation-dependent cell-cell and 
cell-matrix adhesion (Kuwana and Okazaki 2012, Tamkun, et al. 1986, Xiong, et al. 
2001). The cytoplasmic domains are necessary for integrin-mediated signal transduction 
and the connection with the actin cytoskeleton. The head domain of the focal adhesion 
protein talin binds to integrins to form a link to the actin cytoskeleton via two actin 
binding sites in the rod domain (Calderwood, et al. 1999). During pregnancy in mice and 
other mammalian species, integrins are dynamically expressed and regulated within the 
uterus and placenta. Trophoblast adhesion and migration at the onset of implantation in 
rodents are due to changes in expression or distribution of integrin receptors (Sutherland, 
et al. 1993). Receptors for fibronectin (ITGA5B1), laminin (ITGA6B1) (α6β1) and 
vitronectin (ITGAVB3) are expressed continuously throughout the peri-implantation 
period while the expression of other integrin subunits ITGA1 (α1), ITGA2 (α2), ITGA3 
(α3) and ITGA7 (α7) subunits are developmentally regulated during trophoblast invasion 
(Sutherland, et al. 1993). Other integrin subunits (ITGA6, ITGA7) (α6, α7) that can form 
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receptors for laminin are detected only in the differentiating invasive trophoblast 
(Sutherland, et al. 1993). Integrins bind to various extracellular matrix components and 
cell adhesion molecules to transduce cellular signals in uterine epithelial cells and 
conceptus trophectoderm (Burghardt, et al. 2002, Giancotti and Ruoslahti 1999, Hynes 
1992). The number of potential integrin heterodimers and the number and diversity of 
ligands that interact with these integrins, ranging from classical ECM molecules to 
growth factor binding proteins to peptides, accounts for the importance of these 
receptors in the process of epitheliochorial implantation. Due to the non-invasive nature 
of placentation in domestic species, integrins are likely to participate in the mechanical 
coupling of the ECM with the cytoskeleton in uterine LE and conceptus Tr and 
transmittal of signals to affect processes such as conceptus elongation and cellular 
differentiation of cells at the maternal-fetal interface (Burghardt, et al. 2002). In addition 
to roles in implantation or cell attachment to the ECM, integrins play an important role 
in triggering cell signaling cascades in most cell types including EPCs. Integrin 
ITGA5B1, ITGA6B1, ITGAVB3 and ITGAVB5 are involved in EPC homing, invasion, 
differentiation and paracrine factor production while ITGB2s (the β2 integrin subunit) 
are the major regulator of EPC transendothelial migration (Caiado and Dias 2012). 
Chapter II will present data indicating a role for ITGAVs, which are known to promote 
actin polymerization (Zaidel-Bar 2013). The importance of ITGAV subunit during 
implantation is also underscored in the rabbit model where several strategies used to 
inhibit the function of the ITGAVB3 reduced implantation sites (Illera, et al. 2003). In 
human, altered expression of ITGAVB3 correlates with several pathological conditions 
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associated with infertility (Lessey, et al. 1992). Furthermore, paracrine factor production 
by EPCs is also regulated by the integrin-ECM interactions since EPCs plated on 
different matrices (e.g. gelatin, fibronectin, or fibrin) produce different level of paracrine 
factors (e.g. IL-16, platelet derived growth factor-BB, hepatocyte growth factor (HGF), 
etc.) (Barsotti, et al. 2011). 
 
Glucose and Its Transporters 
The oxidation of glucose represents a major source of metabolic energy in 
mammalian species, but the plasma membrane is impermeable to polar molecules such 
as glucose. Therefore, cellular uptake of important nutrients relies heavily on membrane-
associated carrier proteins that bind and transfer them across the plasma membrane 
(Banerjee, et al. 2009). The Human Genome Organization (HUGO) Nomenclature 
Committee Database has organized a list of transporter families of the solute carrier 
(SLC) gene series to help understanding of the huge family of carrier proteins, including 
glucose and amino acid transporters. It includes 43 families and 298 transporter genes 
(Hediger, et al. 2004). Notably, The SLC2 family of glucose transporters comprises 13 
members, including the facilitated-diffusion glucose transporters (GLUT) 1-12 and five 
of these GLUTs (GLUT1 through GLUT4 and GLUT7) have been identified in 
mammals (Uldry and Thorens 2004). The terms SLC and GLUTs are used 
interchangeably in the literature. The former represents the gene name and the latter 
represents a descriptive protein name. In sheep and other ruminants (goats, cows, and 
red deer), GLUT1 was localized to the basal membranes of trophoblast and uterine 
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epithelium while GLUT3 was found at the microvillous junctions between epithelial and 
trophoblast cells of sheep (Wooding, et al. 2005). Also in sheep, the SLC2A1 and 
SLC5A1 mRNAs and proteins were abundant in uterine luminal epithelia and superficial 
glandular epithelia (LE/sGE), while SLC2A4 was present in stromal cells and glandular 
epithelia (GE). SLC2A3 mRNA was not detectable in endometria. SLC2A1, SLC2A3, 
SLC2A4, and SLC5A1 are all glucose transporters that were expressed in the 
trophectoderm and endoderm of conceptuses. However, one of the above-mentioned 
SLC family members is a different type of transporter, i.e., a sodium dependent glucose 
transporter (SGLT). The two known members of the SGLT family are SGLT1 and 
SGLT2, which belong to the SLC5A gene family. Similar to the SLC and GLUT protein 
nomenclature, SLC5A1or SLC5A2 are gene names and SGLT1 or SGLT2 represent the 
corresponding proteins. This type of Na+-glucose cotransporter transports glucose 
against its concentration gradient by coupling its uptake with Na+ that is simultaneously 
transported down its concentration gradient. This is the major mechanism for glucose 
entry into epithelial cells via SGLTs. Glucose can move outward through the basal 
lateral membrane via GLUT and this action does not require Na+ (Lee, et al. 2007). 
Facilitative glucose carriers accelerate the transport of glucose down its concentration 
gradient by facilitative diffusion, a form of passive transport (Banerjee, et al. 2009, Raja, 
et al. 2012). cDNAs have been isolated from human tissues encoding a Na+-glucose-
cotransporter and five functional facilitative glucose transporter isoforms in human 
tissues have been identified (Bell, et al. 1990). As a tissue responsible for the rapid and 
substantial transport of nutrients and molecules, the placenta resembles the intestinal 
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mucosa and renal epithelium, where SGLTs were first discovered as acting via flux 
coupling (glucose cotransport with Na+) (Miller and Bihler 1961, Rajan, et al. 2006, 
Stulc 1997). Certainly the transport of glucose and the expression of glucose is complex 
during pregnancy. Materno-placento-fetal transport of glucose may contribute to 
changes in GLUT1 protein levels, thereby regulating placental and fetal growth (Das, et 
al. 1998). Hyperglycemia has been reported to increase the renal SGLT activities 
through the reactive oxygen species-nuclear factor-kappa B pathways (Lee, et al. 2007). 
Similarly, 72 h of IUGR, ischemic hypoxia, maternal and fetal hypoglycemia led to a 30-
50% decline in placental GLUT1 level in ewes (Das, et al. 1998). 
 
Amino Acids and Their Transporters 
Amino acids are necessary for all living cells and organisms; and their transport 
across plasma membrane depends on specialized transporters. Many amino acids have 
been identified as essential for fetal-placental growth and development including 
arginine, which is an essential amino acid for conceptus growth and development (Li, et 
al. 2010, Wu, et al. 2004, Wu and Meininger 2002).  
A sufficient supply of arginine to the conceptus is particularly important for 
ruminants and pigs (Guillomot, et al. 1993). Increasing L-arginine supplement enhanced 
the reproductive performance of pigs while arginine deficiency is a major factor limiting 
the growth of milk-fed piglets. Maternal undernutrition and hypercholesterolemia in pigs 
are associated with reduced concentrations of arginine in the conceptus as well as 
impaired placental and fetal growth. Polyamines synthesized from ornithine via the 
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arginase pathway and are also important factors placental growth (Mateo, et al. 2007, 
Schoknecht, et al. 1994, Wu, et al. 2007, Wu, et al. 1998). 
The transfer of amino acids across the syncytiotrophoblast layer of the placenta 
involves mediated transport mechanisms at the microvillous and basal membrane in 
addition to diffusion (Smith, et al. 1992). Amino acid transport proteins can be 
distinguished by substrate specificity. Cationic amino acids such as L-arginine, L-lysine 
and L-ornithine share the same transporter with a sodium-independent activity, called 
system y(+) transport (Hosokawa, et al. 1999, McGivan and Pastor-Anglada 1994). The 
transport of L-arginine by system y(+) generated special interest and focus because of its 
potential role in the regulation of nitric oxide synthesis in various types of cells (Lopes, 
et al. 1994, Southam, et al. 1991). Arginine modulates nitric oxide (NO) production and 
blood flow in the vasculature; and endothelium-derived NO plays an important role in 
enhancing blood flow and angiogenesis pregnancy, hence increasing the delivery of 
essential nutrients from the mother to the fetus (Sladek, et al. 1997). Vascular 
endothelial growth factor (VEGF) stimulates the release of NO from cultured HUVECs 
and upregulates the expression of NO synthase (NOS) (Hood, et al. 1998, van der Zee, et 
al. 1997). Endogenous NO produced by nitric oxide synthase (NOS) is partially 
dependent on the cellular uptake of the NOS substrate L-arginine (L-Arg), which 
indicates that the cellular L-Arg transport mechanism plays an important to mediate NO-
dependent function (Kakoki, et al. 2006). The SLC7 family members include the cationic 
amino acid transporters (CATs) and the L-type amino acid transporters (LATs). Both are 
known to play central roles in human physiology and are involved in diseases such as 
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viral infection and cancer. Cationic or positively charged amino acids are transported 
into the cells for protein synthesis as well as conversion of arginine into NO (by NO 
synthase 2) and polyamines (by arginase) (Fotiadis, et al. 2013). CAT proteins are 
amongst the first mammalian amino acid transporters identified at the molecular level 
and seem to be the major entry path for cationic amino acids in most cells. It is known 
that malfunction of transporter proteins can affect systemic homoeostasis resulting in a 
number of human diseases. For example, recessive mutations in the SLC7A7 gene can 
induce inherited aminoaciduria (Toivonen, et al. 2013). 
The expression of the CAT proteins is highly dependent on levels of transcription, 
mRNA stability, translation and localization (Closs, et al. 2006). In sheep, SLC7A1 
mRNA was most abundant in endometrial luminal (LE) and superficial glandular (sGE) 
epithelia on Day 16 of the estrous cycle and on Days 16–20 of pregnancy (Gao, et al. 
2008a). SLC7A2 is one of the novel P4 induced and IFNT stimulated genes in sheep, 
along with previously mentioned facilitated glucose transporter member 1 or SLC2A1 
(Bazer, et al. 2012b). The level and the source of dietary amino acids affect the 
expression of cationic amino acid transporters in pigs fed wheat-based diets (García-
Villalobos, et al. 2012).  
 
Summary and Objectives 
Bone marrow–derived circulating endothelial progenitor cells play a key role in 
blood vessel repair and neovascularization. Because endothelial progenitor cells move 
towards injuries within blood vessels, detecting their presence can lead to a diagnostic 
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system for various vascular diseases. Methods for isolating EPCs from the bloodstream 
have been developed (Plouffe, et al. 2009). Discovery of EPCs has inspired interests in 
the field of vascular biology and their role in in cardiovascular, renal and reproductive 
physiology and in diseases ranging from rheumatoid arthritis to preeclampsia (Caiado 
and Dias 2012, Robb, et al. 2007). EPC angiogenic behavior in vitro can be determined 
by expression levels of integrin receptors ITGA5B1, ITGA6B1, ITGAVB3 and 
ITGAVB5. OPN, which binds these integrins may be involved in angiogenesis by 
upregulating endothelial cell migration in cooperation with growth factors such as VEGF 
(Takahashi, et al. 2002), OPN also binds to integrins ITGAVB3 and ITGA5B1 and 
induces focal adhesion assembly, adhesion and migration of conceptus trophectoderm 
cells during implantation (Bazer, et al. 2012a, Caiado and Dias 2012). Together, 
maternal nutrients including glucose, amino acid (e.g. arginine) and OPN mediate 
growth, migration, cytoskeletal remodeling and adhesion of trophectoderm essential for 
pregnancy recognition signaling and implantation (Bazer, et al. 2012a). In this regard, 
angiogenesis at the fetal-placental interface plays a critical role in nutrient transport in 
this regard and circulating EPC incorporation is very likely to be involved. Since 
conceptuses (embryo/fetus and associated membranes) and uterine endometrium do not 
carry out gluconeogenesis, transport of glucose from the maternal circulation into the 
uterine lumen is essential for pregnancy (Schneider, et al. 1981). Unlike sheep, whose 
GLUTs and SGLTs have been identified in the uterus and peri-Implantation conceptuses, 
there is limited information about the temporal and spatial expression of these amino 
acid transporters during pregnancy in pigs. Mechanisms for glucose and amino transport 
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into the uterine lumen and uptake by conceptuses are not established. SLC2A1, SLC2A4 
and SLC5A1 (mRNA encoding GLUT1, GLUT4 and SGLT1) are present in the LE/sGE 
and GE of pregnant ewes and SLC5A1 mRNA levels were higher in ewes treated with P4 
(Gao, et al. 2009). GLUTs facilitate the transport of glucose across the plasma 
membranes of mammalian cells. SGLTs are sodium-dependent glucose transporters that 
utilize a cotransport mechanism. SGLT1 increases absorption of d-glucose and trigger 
the glucose-induced secretion cytokines and the upregulation of GLUT2 (Gorboulev, et 
al. 2012). In addition to glucose, amino acids, such as arginine, are essential for desired 
fetal growth as well (Li, et al. 2010). Arginase-1 activity is known to increase cell 
proliferation and also to regulate the production of NO (a major mediator of 
angiogenesis. CATs are important regulators of NOS and arginase-1 because they 
regulate L-arginine availability. L-arginine transport is mediated primarily by the Na-
independent System y(+) for cationic amino acids, which has low affinity and high 
capacity in cells (Gao, et al. 2008a). SLC7A1 and SLC7A2 (mRNA encoding CAT1 and 
CAT2) were identified in mouse blastocysts (Gould, et al. 1991). Little information is 
available on developmental changes of CATs in uteri or conceptuses of mammals and 
their affinities for basic amino acids vary greatly (Santos, et al. 2000, Scheepers, et al. 
2004). 
The specific objectives of this thesis and the accompanying hypotheses are (1) to 
identify and determine the physiological mechanisms that promote vascular growth in 
the placenta. The central hypothesis is that OPN binds to EPC integrins, and recruits 
EPCs to sites of neovascularization during pregnancy. The research plan will focus on 
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the communication between EPCs and HUVECs that allows EPCs to incorporate into 
established vascular networks. Previous literature has shown isolated and characterized 
EPCs from the peripheral blood of newborn pigs and shown their expression of integrins 
(Erikson, et al. 2009). We hypothesized that EPCs use specific integrins as 
transmembrane receptors to adhere in vitro on OPN and the number of EPCs that invade 
the matrix in an established 3D collagen matrix system (Bayless, et al. 2009) may 
increase in a dose-dependent manner in the presence of OPN. (2) to determine the 
temporal and spatial expression of glucose transporter SLC5A1 and amino acid 
transporters SLC7A1-3 mRNAs in the endometria and placentae of cyclic and pregnant 
gilts along with the change in levels of glucose, and amino acids within the uterine 
lumen of cyclic and early pregnant gilts. Successful glucose and amino acid supply via 
angiogenesis to the growing fetus are known to be important for fetal growth and 
development. We hypothesize that an increase glucose level in uterine flushing may be 
accompanied by expressional change of SLC5A1 in the endometrium, which may be 
regulated by E2 secreted in during the peri-implantation in pigs. We also hypothesized 
that the expression profile of SLC7A1-3 mRNA in the placenta may explain the currently 
known physiology of an increased arginine transport across the pig placenta in 
gestational period up to day 60 (Wu, et al. 1995). 
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CHAPTER II 
OSTEOPONTIN BINDS TO THE ITGAV (THE ΑV INTEGRIN SUBUNIT) 
PROMOTING PORCINE ENDOTHELIAL PROGENITOR CELL INCORPORATION 
INTO DEVELOPING VASCULATURE 
 
Introduction 
Angiogenesis is the formation of new blood vessels from the existing vasculature 
and is a key step in tissue development, tumor progression and wound healing 
(Carmeliet 2003, 2004, Folkman and D'Amore 1996). Angiogenic growth factors such as 
vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are 
powerful proangiogenic stimuli, and multiple studies have demonstrated the involvement 
of these growth factors and their receptors in mediating angiogenic events. Mice lacking 
VEGF and its receptors fail to form a functional vasculature (Ferrara, et al. 1996, Fong, 
et al. 1995, Shalaby, et al. 1995). However, several additional key cell signaling 
pathways have been identified to mediate angiogenesis and are initiated by integrins and 
other cell surface receptors, growth factors, lipids and the extracellular matrix (ECM). 
Integrins are heterodimeric transmembrane cell receptors composed of noncovalently 
linked α and β chains that serve as a link between the cellular cytoskeleton and ECM 
(Giancotti and Ruoslahti 1999). The ITGA2B1 (α2β1) integrin is an endothelial receptor 
for collagen type I (Elices and Hemler 1989) and is necessary for angiogenesis both in 
vivo and in vitro (Davis and Camarillo 1996, Drake and Little 1991, Senger, et al. 2002). 
Other integrins, including ITGA1B1, ITGAVB3 and ITGA5B1, have also been 
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demonstrated to be involved in angiogenesis (Bayless, et al. 2000, Davis and Bayless 
2003, Senger, et al. 1997). Mice lacking ITGAV (Bader, et al. 1998) and ITGA5 (the α5 
integrin subunit) receptors (Yang, et al. 1993 ) result in an embryonic lethal phenotype. 
Thus, these studies support a key role for integrins in shaping vascular formation in the 
embryo and adult.  
During pregnancy, uterine and placental blood vessels grow and/or dilate to 
facilitate maximal transfer of nutrients from maternal to placental vasculatures for 
hematotrophic support of the developing conceptus. OPN is a candidate ECM protein for 
promoting angiogenesis in the uterus during pregnancy. In gilts, OPN expression 
increases in scattered cells in the stratum compactum directly beneath the uterine 
luminal epithelium (LE) between Days 9 and 12, and again between Days 30 and 40 of 
gestation, where angiogenesis is actively occurring within the pregnant uterus (Garlow, 
et al. 2002). OPN has also been linked to angiogenesis in other systems. OPN induces 
tumor cell-induced angiogenesis in mice (Hirama, et al. 2003, Takahashi, et al. 2002), 
and enhances vascularization in ectopic bone (Asou et al., 2001). However, the precise 
role of OPN in facilitating angiogenesis during porcine pregnancy remains unknown.  
Blood vessels are structurally comprised of a luminal layer of endothelial cells that is 
surrounded by a basement membrane and vascular smooth muscle cells that form the 
vessel wall. Recently, senescent sloughed endothelial cells and endothelial progenitor 
cells (EPCs) have been identified as normal components of circulating blood and may be 
involved in numerous pathologies (Bertolini, et al. 2007, Bertolini, et al. 2006, 
Kawamoto and Losordo 2008). EPCs are mononuclear endothelial cell precursors 
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originating from the hematopoietic compartment of bone marrow that are mobilized into 
the circulation, where they are thought to be recruited to areas of angiogenesis (Asahara, 
et al. 1999, Brunt, et al. 2007). Several studies have shown that EPCs are involved in 
endogenous neovascularization of ischemic tissues (Brunt, et al. 2007, Dimmeler, et al. 
2005, Dzau 2005). EPCs from blood can be isolated and identified based on in vitro 
adhesion characteristics and by cell surface markers. As EPCs differentiate in culture, 
they acquire endothelial cell markers such as VE-CAD, PECAM-1 and von vWF (Parant, 
et al. 2009, Urbich and Dimmeler 2004). However, no cell surface markers unique to 
EPCs have been identified that allow definitive isolation of these cells (Hirschi, et al. 
2008). Asahara and coworkers identified EPCs as a population of CD34 expressing cells 
that were more adherent to fibronectin than type I collagen and displayed a spindle-
shaped morphology (Asahara 1997). Lin et al. isolated peripheral blood mononuclear 
cells from patients that had undergone bone marrow transplantation and reported the 
emergence of highly proliferative endothelial cells 14 to 21 days after isolation from a 
marrow origin (Lin, et al. 2000). These cells were called endothelial colony forming 
cells (ECFCs) and displayed characteristics of EPCs, as well as the ability to form blood 
vessels in vivo (Melero-Martin, et al. 2007, Shepherd 2006, Yoder, et al. 2007).  
OPN is well-suited to recruit EPCs to sites of active angiogenesis. OPN can 
regulate various monocyte functions, including the recruitment of proangiogenic 
monocytes (Leali, et al. 2003), prevention of reverse transmigration (recirculation), and 
enhancement of survival of cells of a monocyte/macrophage lineage (Burdo, et al. 2007). 
Supernatants from OPN-treated monocytes are highly angiogenic (Naldini, et al. 2006). 
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OPN-/- mice exhibit significantly decrease in total hind limb vascular volume after 
induction of hind limb ischemia compared with wild type mice, suggesting that OPN is 
needed for collateral vessel formation and successful angiogenesis (Duvall, et al. 2007). 
In addition, a 32 kDa OPN fragment produced by matrix metalloproteinase (MMP) 
cleavage binds strongly to the surface of endothelial cells (Gao, et al. 2004). These data 
imply that OPN modulates the migration and proangiogenic activity of mononuclear and 
endothelial cells in the progression of new blood vessel formation. 
OPN and EPCs are both upregulated during inflammation, pathologic 
angiogenesis and pregnancy. OPN is chemoattractant to epithelial cells, which is what 
EPCs differentiate into (Apte, et al. 2005, Asahara 1997, Asou, et al. 2001, Bailey, et al. 
2010, Buemi, et al. 2007, Caiado and Dias 2012, Denhardt and Guo 1993, Duvall, et al. 
2007, Erikson, et al. 2009, Garlow, et al. 2002, Gomer 2008, Hristov, et al. 2003, 
Matsubara, et al. 2006, White, et al. 2005). Based on the above characteristics of OPN 
and EPCs, we hypothesize that OPN expressed within the stratum compactum stroma of 
the pig uterus during early pregnancy functions to recruit EPCs to sites of 
neovascularization. The objectives of this study were to isolate and identify EPCs from 
peripheral pig blood and determine the effect of OPN on EPC adhesion and invasion in 
vitro.  
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Materials and Methods 
Experimental Design 
Experimental and surgical procedures involving animals as a source of porcine 
endothelial progenitor cells (EPCs) as well as uterine/placental frozen sections complied 
with the Guide for Care and Use of Agricultural Animals and were approved by the 
Institutional Agricultural Animal Care and Use Committee of Texas A&M University. 
 
Study One 
Blood was obtained from newborn piglets, and used to isolate and culture EPCs. 
RNA was extracted using RNeasy® Mini Kit (Qiagen, Valencia, CA) for RT-PCR 
analysis to identify CD31, VEGFR2, CDH5, CD14, CD34, CD45 and integrins subunits 
ITGAV, ITGA4, ITGA5, ITGB1, and ITGB5 (αv, α4, α5, β1 and β5). Endothelial markers 
vWF, PECAM and VE-CAD were evaluated on the purified cells by 
immunofluorescence analysis. Affinity chromatography and immunoprecipitation were 
performed using biotin-labeled EPC extracts mixed with OPN-Sepharose (Sigma, St. 
Louis, MO) to test whether the ITGAV (the αv integrin subunit) on EPCs binds directly 
to OPN.  
 
Study Two 
ITGAV (the αv integrin subunit) or GAPDH expression in EPCs was silenced using 
siRNA (75 nM) (Ambion, Carlsbad, CA) and knockdown of protein was confirmed by 
western blot analysis. Immunofluorescence staining against ITGAV and other focal 
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adhesion proteins including FAK, paxillin and vinculin were also analyzed. Adhesion 
assays were performed to investigate the ability of EPC’s to bind recombinant rat OPN 
(rOPN) and bovine milk OPN (bOPN).  
 
Study Three 
Human umbilical vein endothelial cells (HUVECs) were cultured on a monolayer 
at the surface of 3D collagen matrices as previously described (Bayless, et al. 2009). In 
this model, endothelial cells can invade to the matrix and form multicellular tubes with 
open lumens and branching structures similar to angiogenic vessels in vivo. 
Incorporation of EPCs into invading HUVEC structures were observed in HUVEC-EPC 
cocultures. We tested whether the addition of soluble OPN enhanced incorporation of 
EPCs labeled with the fluorophore DiI into invading HUVEC structures. 
 
Study Four 
This experiment was designed to evaluate whether OPN binds ITGAV on EPCs to 
increase EPC incorporation in coculture with HUVEC. HUVEC were cultured with 
control EPCs or EPCs treated with siRNA directed to ITGAV or GAPDH. Following 
gene knockdown EPCs were labeled with DiI and placed in co-cultures with HUVEC in 
the presence of 0, 30 and 100 µg/ml OPN. Cells were collected for immunofluorescence 
analysis and protein samples were extracted from all groups to confirm successful 
knockdown of ITGAV or GAPDH as described for study two. 
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EPC Isolation and Culture 
The porcine endothelial progenitor cell line pEPC was isolated and cultured 
following a combination of two methods for purifying EPCs from human blood (Brunt, 
et al. 2007, Hirschi, et al. 2008). Whole blood (50 c.c.) was obtained from piglets within 
6 h of birth, diluted 1:1 in PBS and layered over Ficoll-Paque (Invitrogen, Carlsbad, CA). 
Following centrifugation (400 x g, 20 min), the mononuclear cell layer was transferred 
to a new tube and washed twice with sterile phosphate-buffered saline (PBS) (1500 x g, 
5 min). Cells were then resuspended in medium-199 (M199) containing 100 µg/ml 
heparin (Sigma, St. Louis, MO), 0.4 mg/ml lyophilized bovine hypothalamic extract 
(Pel-Freeze Biologicals, Rogers, AK) and 15% fetal bovine serum (Lonza, no. 14-471F, 
Walkersville, MD) and cultured on flasks coated with 5-10 µg/ml fibronectin (Invitrogen, 
Carlsbad, CA) in this medium. After one h, nonadherent cells were removed, the flask 
was washed, and fibronectin-adherent cells were cultured for 14-21 days or until a 
confluent monolayer of cells was obtained. At this time, cells were passaged onto gelatin 
(Sigma-Aldrich, cat. no. G2500, St. Louis, MO)-coated flasks (1 mg/ml) and used for the 
experiments outlined below. 
 
Immunofluorescence 
EPCs were seeded onto four-well chambered slides coated with fibronectin and 
cultured overnight (37°C, 5% CO2). Cells were washed once in PBS and fixed in 2% 
paraformaldehyde (PFA) (Electron Microscopy Sciences, cat. no. 15712, Hatfield, PA)) 
in PBS, then permeabilized in PBS containing 1% Triton X-100. Immunofluorescence 
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staining was performed as previously described (Johnson, et al. 2001). After washing 
with PBS containing 0.3% vol/vol Tween 20, cells were blocked with 10% vol/vol goat 
serum and incubated overnight at 4°C with 20 µg/µl rabbit polyclonal antibodies to vWF, 
VE-CAD (Enzo Life Sciences, Farmingdale, NY) or PECAM (Santa Cruz, Dallas, 
Texas). Tissue-bound primary antibodies were detected with goat anti-rabbit IgG Alexa 
488 (Chemicon, Temecula, CA). Rabbit IgG at the same concentration as the primary 
antibody was used as a negative control. Slides were overlaid with ProLong® Gold 
antifade reagents with DAPI (Life Technologies –Invitrogen, cat. no. P-36931, Carlsbad, 
CA) and a cover glass. 
 
Integrin Affinity Chromatography 
To identify porcine EPC (pEPC) integrins that directly bind to OPN, affinity 
chromatography experiments were performed (Bayless, et al. 1997, Bayless, et al. 1998, 
Erikson, et al. 2009). Bovine milk OPN extracted as previously described (Bayless, et al. 
1997) was coupled to cyanogen bromide-activated Sepharose® 4B (Sigma, St. Louis, 
MO) at 1 mg/ml according to the manufacturer’s instructions. Surface biotinylation of 
pEPCs was performed as previously described (Bayless, et al. 1998, Erikson, et al. 2009). 
Porcine EPCs were surface-labeled with biotin in 75 cm2 flasks for 1 h at room 
temperature and washed with PBS. Cells were lysed with 50 mM octyl-β-D-
glucopyranoside (OG) (Fisher Scientific, Pittsburgh, PA) containing 1.5 mM MnCl2 and 
MgCl2 for 30 min on an orbital shaker at 4°C. Cell extracts were centrifuged and then 
mixed at 20 min intervals with OPN-Sepharose® (0.5 ml) for 2 h at 0°C. The column 
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was washed with 20 ml of 1% OG plus Mg2+ and Mn2+, and 0.5 ml fractions were eluted 
with 4 ml of 1% wt/vol OG + 10 mM EDTA. Thirty µl of each fraction were separated 
on a 7% polyacrylamide gel under non-reducing conditions, transferred to 
polyvinylidene difluoride (PVDF) and blocked for 30 min with 5% wt/vol nonfat dry 
milk in Tris-buffered saline containing 0.1% vol/vol Tween 20. Blots were probed for 
biotin using streptavidin-alkaline phosphatase as previously described (Bayless, et al. 
1997, Bayless, et al. 1998). 
 
Integrin Immunoprecipitation 
Protein samples were incubated with 2 μg of the rabbit antisera directed to integrins 
ITGA4 (AB1924), ITGA5 (AB1928), ITGAV (AB1930), ITGB1 (MAB1981;), ITGB3 
(AB1968), ITGB6 (the β6 integrin subunit) (MAB2076Z), ITGAVB3 (MAB1976Z), or 
ITGAVB5 (MAB1961) (All from Chemicon, Temecula, CA) in 500 μl of lysis buffer 
containing 0.5% Nonidet P-40 overnight at 4 °C with gentle shaking. 20 μl of protein G 
Dynabeads® (Invitrogen, cat. no. 10003D, Carlsbad, CA) were added to each sample, 
incubated for another 2 h, and washed extensively. Magnetic beads were suspended in 
1× Laemmli sample buffer (Santa Cruz Biotech, cat. no. 161-0737, Dallas, TX) 
containing 2% β-mercaptoethanol for Western blot analyses. 
 
RT-PCR Analyses 
Partial mRNAs (3 µg) for pEPCs were amplified by RT-PCR using tRNA from 
different passages. CD14, CD31, CD34 CD45, VEGFR2, CDH5, ITGAV, ITGA4, ITGA5, 
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ITGB1, ITGB3, ITGB5, ITGA2 (α2 subunit), ITGA10 (α10 subunit), ITGA11 (α11 subunit) 
primers (Invitrogen, San Diego, CA.) were derived from the swine the swine mRNA 
coding sequence. All products were amplified along with a beta-actin control using a 
SuperScript® III Reverse Transcriptase Kit (Invitrogen, cat. no. 18080-051 San Diego, 
CA). The PCR amplification procedure were : 1) 95℃ for 2 min; 2) 58C for 30 sec, 
50C for 45 sec, and 72C for 1 min for 25 cycles; and 3) 72C or 7 min. All samples 
were loaded in 2% agarose gel containing Bio-Safe (Bio-Rad, Hercules, CA) for 
electrophoresis at 100 V for 1 h. Images were captured by UVP PhotoDoc-It™ Imaging 
Systems fitted with a Canon A480 digital camera in benchtop UV transilluminator (UVP, 
LLC Upland, CA).  
The following gene-specific primer sets were used: CD14 (5’- GTTGCTGCTG 
CTGCTGCC-3’ and 5’-AAGTTGCAGACGCAGCGGA-3’). CD31 (5’-GAACGGAAG 
GCTCCCTTGA -3’ and 5’-AGGGCAGGTTCATAAATAAGTGC -3’). CD34 (5’-
GATTGCACTCGTGACCTCGG-3’ and 5’-TCCGTGAATAAGGGTCTTCGC-3’). 
CD45 (5’-TGGTGGAATACAATCAGTTTGGAG-3’ and 5’-CCAATGT GCTGTGTC 
CTCCAG-3’). VEGFR2 (5’-TCACA ATTCCAAAAGTGATCGG-3’ and 5’-GGTCA 
CTAACAGAAGCAATAAATGG-3’) CDH5 (5’-CAACGAGGGCATCATCAAGC-3’ 
and 5’-TCGATGGTGGGGTCTGCGG-3’. ITGAV (5’-CTGGTCTTCGTTTCAGTGTG 
C-3’ and 5’-GCCTTGCTGAATGAACTTGG-3’). ITGA4 (5’-CAGATGGGATCTCGT 
CCACC-3’ and 5’-TCTGCTGGACACCTGTATGC-3’). ITGA5 (5’-GAGCCTGTGGA 
GTACAAGTCC-3’ and 5’-CCTTGCCAGAAATAGCTTCC-3’. ITGB1 (5’-GACCTGC 
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CTTGGTGTCTGTGC-3’ and 5’AGCAACCACACCAGCTACAAT-3’). ITGB3 (5’-
AGATTGGAGAACACGGTGAGC-3’ and 5’-GTACTTGCCCGTGATCTTGC-3’. 
ITGB5 (5’-TCAACAAGTTCAACAAGTCCTACAA-3’ and 5’-ATCTCAGCAGTTCA 
GTGAGAAGAC-3’). ITGAII (αii subunit) (5’TGCTCAGCTTCAATGTGTCC -3’ and 
5’-GCAGCTCCAGCACATTATCA-3’). ITGA10 (α10 subunit) (5’-TCATTCAGATTCC 
TTCTACATCCTC -3’ and 5’-GAATTGTACAGAATGTGTTGTGG-3’). ITGA11b 
(α11b subunit) (5’-GAGTTCCTACTACACCACGAATG -3’ and 5’-ATCTTTTACAGA 
CCGGGTACATTG -3’). 
 
ITGAV and GAPDH Knockdown Using siRNA 
The following small interfering RNA were obtained from Ambion (Carlsbad, CA): 
ITGAV (5’-CCAACUUCAUUAUAGAUUU-3’ and 5’-AAAUCUAUAAUGAAGUUG 
G-3’). GAPDH (5’-GCCUCAAGAUCAUCAGCAAtt-3’ and 5’-UUGCUGAUGAUCU 
UGAGG-3’). siRNA stocks (5nmol) were resuspended in 50µl nuclease free H2O (100 
µM) and stored at -20°C. 3.9 µl of siRNA was mixed with 906.1 µl Opti-MEM® (Life 
Technologies–Invitrogen, cat. no. 31985-062, Carlsbad, CA) (final concentration = 75 
nM). In a separate tube, 15.6 µl small interfering RNA carrier siPORT™ amine (Life 
Technologies–Invitrogen, cat. no. AM4502, Carlsbad, CA) was mixed with 894.4 µl 
Opti-MEM®. Mixtures containing siRNA and siPORT amine were combined and 
incubated for at least 10 min at room temperature. 80% confluent pEPCs (0.8 x 106cells) 
were resuspended in antibiotic-free 0.8 ml DMEM and seeded onto 1mg/ml gelatin in 
PBS-coated T25 flasks. Antibiotic-free DMEM was added to adjust the final volume to 
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5.2 ml. After 8 h of transfection, cultures were spiked with 5.2 ml growth medium 
without antibiotics. Endothelial growth medium was prepared by combining 500 ml 
M199, 0.2 g lyophilized endothelial growth supplement, heparin, and 12.5% fetal bovine 
serum as previously described (Bayless, et al. 2009). Medium was changed after 24 h 
and the cells were allowed to grow for another 48 h (37°C, 5% CO2) prior to use. 
 
Protein Extraction and Western Blot Analysis 
3.8x 105 EPCs (40% of a confluent T25 flask) were trypsinized and centrifuged 
(350 xg, 3.5 min) and were extracted in 400 µl RIPA lysis buffer with protease inhibitors 
(Sigma, cat. no. P8340, St. Louis, MO) and 3X protein sample buffer. Proteins in cell 
extracts (30 µl per lane) were separated on 8% SDS-PAGE gels under non-reducing 
conditions, and transferred to PVDF membrane for 2 h with methanol on ice. Blots were 
then blocked with 2% milk on the shaker for 1 h at room temperature, incubated with 
milk containing polyclonal rabbit ITGAV antibody (EMD Millipore, AB1930, Billerica, 
MA) at 1:1000 dilution, mouse GAPDH (Abcam, AB9483, Cambridge, MA) at 1:10000 
dilution, and mouse alpha tubulin (Enzo Life Sciences, cat. no. IMG-80196, 
Farmingdale, NY) at 1:10000 dilution overnight at 4°C with gentle mixing and then 
incubated in corresponding rabbit or mouse HRP-conjugated secondary antibodies 
(Dako, Carpinteria, CA) at 1:5000 dilution in milk for 1 h at room temperature. 
Immunoreactive proteins were detected using Immobilon Western Chemiluminescent 
HRP Substrate (2 ml per blot) (EMD Millipore, lit. no. P36599A Billerica, MA) and 
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blots were developed then scanned by HP Scanjet G3010 Photo Scanner (Hewlett-
Packard, Palo Alto, CA). 
 
Cell Attachment Assays 
Cell attachment assays were conducted as previously described (Bayless, et al. 1998, 
Erikson, et al. 2009). High-binding polystyrene microwells (Corning-Costar, no. 3690, 
Corning, NY) were coated overnight at 4°C with 50 µl of the following proteins in 
phosphate buffered saline (PBS) (n=3 replicates/treatment): The thrombin fragment of 
rat OPN containing intact RGD binding sequence (RGD) or the mutated RAD sequence 
(RAD) (plasmids were a gifts from Dr. Magnus Hook, Texas A&M Institute of 
Biosciences & Technology) (McFarland, et al. 1995), bovine OPN (bOPN), bovine 
fibronectin as positive control (bFN) or bovine serum albumin as negative control (BSA). 
Proteins were coated at concentrations ranging from 0 - 20µg/ml. After blocking each 
well in 10 mg/ml BSA in PBS (100 µl), 50,000 pEPC cells were added per well and 
allowed to attach for 1 h (37°C, 5% CO2). In all cell attachment experiments, 
nonadherent cells were removed by washing in isotonic saline and wells were fixed in 
4% formalin in PBS. Plates were stained with 0.1% wt/vol Amido black in 10% acetic 
acid and 30% methanol for 15 min, rinsed and solubilized with 50 µl 2 N NaOH to 
obtain an absorbance reading at 595 nm which directly correlated with the number of 
cells stained in each well (Davis and Camarillo 1993, 1996). To demonstrate that 
binding of pEPCs to OPN was integrin-dependent, an attachment assay was performed 
in which levels of cations were varied. Polystyrene microwells (Corning-Costar, Corning, 
 38 
 
NY) were coated overnight at 4°C with 20 µg/ml of bOPN, rOPN, collagen I, bFN and 
blocked for 1 h with 10 mg/ml BSA. Cells were washed in cation-free Puck’s Saline A 
(PSA) (Sigma, St. Louis, MO), and resuspended in PSA containing 100 µg/ml BSA. 
Cells were allowed to attach for 1 h in either PSA with 2 mM Ca2+ 1 mM Mg2+ or PSA 
with no cations (n=3 replicates/treatments)  
 
Collagen Gel Invasion Assays 
Collagen type I was prepared from rat tail tendons by non-proteolytic isolation 
using acetic acid (Sigma, cat. no. A6283, Louis, MO) as previously described (Bayless, 
et al. 2009, Bornstein 1958 , Rajan, et al. 2006). Collagen matrices were prepared on ice 
by combining 350 µl of collagen type I (7.1 mg/ml), 39µl 10X M199 (Invitrogen, cat. no. 
11825-015, Carlsbad, CA), 2.1 µl 5N NaOH, and 609µl M199 (Gibco–Invitrogen, cat. 
no. 11150, Carlsbad, CA) to reach a final concentration of 2.5 mg/ml. 80 µl of the 
mixture was added to each 6.5 mm Transwell® with 3.0 µm pore polyester membrane 
insert in a 24 well plate (Corning-Costar, lot. 12602010, Corning, NY). Confluent 
pEPCs (passage 22-26) and HUVECs (passage 3-6) were washed with HEPES buffered 
saline (150 mM NaCl, 50 mM HEPES (pH 7.4) before trypsinization from T75 flasks. 
Cells were resuspended at 40,000 (HUVEC) and 30,000 (EPCs) cells per 10 μl in M199 
based on counts obtained from Cellometer® Auto 1000 (Nexcelom Bioscience, 
Lawrence, MA) or Bright-line hemacytometer (VWR, cat. no. 15170-168, Radnor, PA). 
EPCs were labeled in a 1ml volume with 1 µM CellTracker™ CM-DiI (1 µl in 1 ml 
(3x106) cells) (Molecular Probes®, cat. no. C-7001, Eugene, OR) for 15 min at 37 °C. 
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Cells were washed four times with 1ml of M199 following repeated centrifugations (350 
xg, 3.5 min) to remove excessive DiI. 10 μl of HUVEC (40,000 cells) and DiI-labeled 
EPC (30,000 cells) were added into each well insert. 100 μl suspension of equilibrated 
M199 containing Reduced serum II (RSII) (Bayless et al., 2009) (1:250), vascular 
endothelial growth factor (VEGF) (40 ng/ml, R&D, 293-VE, R&D Systems, 
Minneapolis, MN), basic fibroblast growth factor (bFGF) (40 ng/ml, 234-FSE, R&D 
Systems, Minneapolis, MN) and ascorbic acid (50 μg/ml) were added on the top of each 
polymerized collagen matrices. 1 ml of the medium was added into the well under each 
insert with 1 µM sphingosine-1-phosphate (S1P) (Avanti Polar lipids, cat. no. 860492, 
Alabaster, AL). Both top and the bottom media were supplemented with 12-O-
tetradecanoylphorbol-13-acetate (TPA) (50 ng/ml) (Sigma, cat. no. P1585, Louis, MO). 
In experiments testing the effects of OPN, bOPN or PBS vehicle was added into lower 
chambers at a final concentration of 0, 30, and 100 µg/ml. After 24 h of incubation 
(37°C, 5% CO2), the top medium (100 μl) was replaced with fresh medium after 
washing with HEPES. All inserts were washed with PBS without cations, fixed in 4% 
PFA overnight and then stained with 1µM DAPI (Molecular Probes®, cat. no. D1306, 
Eugene, OR) for at least 30 min at room temperature (or 4°C overnight) and stored in 
double-distilled water for further analysis. 
 
Cell Counting 
Filter membranes from each insert were removed by scalpel blade prior to pushing 
collagen matrices outside of each insert with capped 25½G needles (Becton Dickinson, 
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Franklin Lakes, NJ). All invading cells were counted using an Olympus CKX41 
microscope (Olympus, Center Valley, PA) with an eyepiece equipped with a reticle 
displaying a 10 x 10 grid (Olympus, Center Valley, PA). Monolayers were identified 
under the fluorescence DAPI channel initially, and then all DAPI or DiI stained cell 
nuclei below the surface were considered invading cells as the focus was adjusted up and 
down routinely to avoid duplicate counting. The center field was selected for 
quantification in each gel (n=3) and the total number was averaged for each experiment. 
 
Statistical Analyses 
Data were processed by analysis of variance (ANOVA) and presented with standard 
error (SE). Tests of statistical significance were performed using the appropriate error 
terms according to the expectation of the mean squares for error. 
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Results 
Purified EPCs Developed an Endothelial-like Phenotype in Culture 
RT-PCR analysis of EPCs isolated from newborn piglets indicated that 
expression of endothelial markers CD31, VEGFR2, and CDH5 increased from passage 1 
to passage 16, while expression of monocyte markers, CD14 and CD45 decreased with 
passage. The expression of CD34 remained constant (Fig.2.1a). Thus, these RT-PCR 
data suggest cultured pig EPCs develop an endothelial-like phenotype in culture.  
 
 
 
 
 
 
Fig. 2.1a. RT-PCR of surface markers in cultured porcine EPCs. RNA extracted from 
EPCs at different passages (P) was subjected to reverse transcription-PCR using primer 
sets specific for CD14, CD31, CD34, CD45, CD133, vascular endothelial growth factor 
receptor 2 (VEGFR2), vascular endothelial cadherin (VE-CAD; CDH5). Expression of 
CD31, VEGFR2, CDH5, increased from passage 1 to passage 16, while expression of 
CD14, CD45 decreased with passage. CD133 were undetectable while CD34 remained 
constant. 
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Immunofluorescence analysis for vWF, PECAM-1 (CD31), VE-cadherin (VE-
CAD; CDH5) in isolated pEPCs was performed to confirm RT-PCR data. Photographs 
shown in Fig 2.1b indicated cobblestone morphology, consistent with an endothelial cell 
phenotype. PECAM, and VE-CAD were expressed in a pattern consistent with 
endothelial cell junctions, and vWF localization appeared to be consistent with Weibel-
Palade bodies (Wagner, et al. 1982). No staining was seen with IgG control, as expected. 
Thus, the purified porcine EPCs express endothelial marker proteins at the expected 
patterns in culture (Fig. 2.1b).  
 
 
 
 
 
 
Fig. 2.1b. EPCs express endothelial markers in culture. Differential interference contrast 
(DIC) image demonstrating morphology of EPCs (width of field = 1000 μm, top left). 
Immunofluorescence analysis (width of field = 130 μm) of EPCs shows expression of 
several endothelial markers including vWF, VE-CAD and PECAM-1. Pre-immune 
rabbit IgG (rIgG) was used as a negative control. 
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In addition to testing whether pEPCs expressed endothelial markers, RT-PCR 
analyses were also conducted to determine integrin expression profiles. Cultured pEPCs 
(passage 22) express multiple integrin subunits (Fig 2.2a). 
 
 
 
 
 
 
Fig. 2.2a. RT-PCR analysis of integrin subunits expressed in EPCs. RNA extracted from 
EPCs passage 22 was subjected to reverse transcription-PCR using primer sets specific 
for the integrin subunits ITGAV, ITGA4, ITGA5, ITGB3, ITGA2, ITGA10, and ITGA11. 
A band indicates the presence of a particular integrin subunit. 
 
 
 
To determine which of the various integrin subunits present on EPCs might 
interact directed with OPN, affinity chromatography was performed using biotin-labeled 
EPC membrane extracts mixed with OPN-Sepharose beads. Analysis using streptavidin-
alkaline phosphatase clearly showed the binding of OPN to integrin α and β subunit (Fig. 
2.2b). Elution fractions E2-E4 were pooled and precipitated using antisera specific to 
integrin subunits. Immunoprecipitation results indicated that ITGAV from EPCs is 
binding to OPN (Fig. 2.2b). 
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Fig. 2.2b. ITGAV on EPCs directly bound OPN. Left panel: Affinity chromatography 
experiments. Biotin-labeled EPC membrane extracts were mixed with OPN-Sepharose 
and bound integrins eluted with EDTA. Right panel: Immunoprecipitation studies. 
EDTA elution fractions E2-E4 were pooled and combined with various antibodies 
directed to the integrin subunits indicated and protein G Sepharose overnight. Beads 
were washed and boiled. Supernatants were separated by non-reducing SDS-PAGE, 
transferred to PVDF and analyzed using streptavidin-alkaline phosphatase. 
 
ITGAV Silencing Reduced EPC Binding to OPN and Focal Adhesion Assembly 
ITGAV expression in EPCs was confirmed using immunofluorescence (Fig. 
2.3a). The expected punctate pattern consistent with localization to focal adhesions was 
observed. 
  
 
 
 
 
Fig. 2.3a Immunofluorescence staining of ITGAV in EPC. EPCs were stained (width of 
field = 130 μm) using antisera directed to the ITGAV subunit (AB1930; Chemicon, 
Temecula, CA). 
 45 
 
In addition, EPCs attach to recombinant rat OPN in an RGD-dependent manner 
(Fig. 2.3b), which supports a role for the v integrin, as well as other RGD-binding 
integrins in recognizing OPN.  
 
 
 
 
 
 
Fig. 2.3b. EPCs dose-dependently bound to recombinant rat RGD in an RGD-dependent 
manner. EPCs dose-dependently binding to recombinant rat OPN containing an RGD 
sequence, but not the mutated RAD control, indicating a dependence on the RGD 
sequence to promote EPC attachment to OPN. Adhesion assays were conducted with 
recombinant rat OPN with an intact integrin binding sequence (RGD) rat OPN with a 
mutated integrin binding sequence (RAD). Plates were coated with the indicated 
concentration of proteins overnight and blocked with BSA. pEPCs were allowed to 
attach for 1 h before nonadherent cells were removed. Adherent cells in all attachment 
experiments were fixed, stained with Amido black, and quantified. Values represent 
absorbance readings (595 nm; 3 wells/data point). 
 
To confirm a functional role for ITGAV in mediating EPC attachment to OPN, 
siRNA experiments were conducted. Decreased expression of ITGAV was confirmed in 
the ITGAV-siRNA group using western blot analyses and immunofluorescence staining 
compared with a GAPDH-siRNA control (Fig. 2.4a).  
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Fig 2.4a. Successful silencing of ITGAV expression in pEPCs using siRNA. Left panel: 
Western blots confirming successful knockdown of ITGAV and GAPDH by their 
respective siRNA targeting sequences (75 nM, 48 h transfection). Proteins in cell 
extracts (30 µl per lane) were separated on 8% SDS-PAGE gels under non-reducing 
conditions, and transferred to PVDF membrane for 2 h with methanol on ice. Blots were 
then blocked with 2% milk on the shaker for 1 h at room temperature, incubated with 
milk containing polyclonal rabbit ITGAV antibody at 1:1000 dilution, mouse GAPDH at 
1:10000 dilution, and mouse alpha tubulin at 1:10000 dilution overnight at 4°C and then 
incubated in corresponding HRP-conjugated secondary antibodies at 1:5000 dilution in 
milk for 1 h at room temperature. Immunoreactive proteins were detected using 
Immobilon Western Chemiluminescent HRP Substrate (2 ml per blot) and blots were 
developed and scanned for analysis. Right panel: Immunofluorescence staining showing 
ITGAV knockdown in EPC. Immunofluorescence analysis confirmed the decreased 
expression of ITGAV using siRNA directed to ITGAV, but not GAPDH siRNA controls. 
The arrows represent the signals of focal adhesion formed using ITGAV (width of field 
= 130 μm). 
 
Fig 2.3b demonstrates pEPCs attach to OPN in an RGD-dependent manner. To 
test whether the ITGAV is required for binding to OPN, EPCs treated with no siRNA 
(CON) or siRNA directed to ITGAV or GAPDH control were tested for the ability to 
attach to various extracellular matrix proteins. Wells were coated with bOPN, rOPN, 
bovine fibronectin (bFN), and collagen type I (COL I). Experiments were conducted as 
described in Fig 1a. Silencing ITGAV decreased EPC bind to bOPN, rOPN and bFN (Fig 
2.4b). No effect of ITGAV siRNA was seen on EPC adhesion to COL I, as ITGAV 
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integrins are not involved in collagen binding (Fig 2.4a). Consistent adhesion to all 
substrates was observed with siRNA directed to GAPDH, as well as non-transfected 
CON. Little adhesion was seen on BSA substrate, as expected.  
 
 
 
 
 
 
Fig. 2.4b. ITGAV is required for EPC attachment to OPN. Adhesion testing whether 
EPC binding to OPN is ITGAV dependent. Adhesion assays were conducted with 
multiple matrix proteins, including bovine OPN (bOPN), recombinant rat OPN with an 
intact integrin binding sequence (rOPN), bovine fibronectin (bFN), and collagen type I 
(COL I). Plates were coated with 20 μg/ml of proteins overnight and blocked with BSA. 
EPCs were allowed to attach for 1 h before nonadherent cells were removed. Adherent 
cells were fixed, stained with Amido black, and quantified. Bovine serum albumin (BSA) 
served as a negative control and collagen type 1 (COL1) served as a positive control.) 
Values represent absorbance readings (595 nm; 3x3 wells/data point). 
 
The cell adhesion experiments in Fig 2.4b indicate a decreased ability of EPCs to 
attach to bOPN, rOPN, and bFN. Because focal adhesions have been implicated in 
mediating cell attachment (Dumbauld, et al. 2013), immunofluorescence staining was 
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conducted with control (non-transfected) EPCs and EPCs treated with siRNA directed to 
ITGAV and GAPDH (Fig 2.4c). Following siRNA treatment, EPCs were placed on 
coverslips and coated with 1mg/ml gelatin and stained for the focal adhesion proteins 
focal adhesion kinase (FAK), vinculin, and paxillin. Similar staining patterns were 
observed in CONTROL and GAPDH siRNA-treated EPCs, which is consistent with 
punctate staining patterns of cells in culture. However, EPCs treated with ITGAV siRNA 
showed a decrease in vinculin and paxillin staining, while FAK was not overtly affected. 
No staining was seen in IgG controls. 
 
 
 
 
 
 
Fig. 2.4c. Silencing of ITGAV reduces vinculin and paxillin incorporation into focal 
adhesions. Immunofluorescence staining of focal adhesion proteins in control (non-
treated) EPCs, and EPCs treated with ITGAV and GAPDH siRNA (75 nM, 48 h 
transfection). Cells were plated on coverslips and stained with antibodies directed to 
FAK, vinculin, and paxillin, as well as IgG controls (width of field = 130 μm). 
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EPCs do Not Invade on Their Own, but Incorporate into Sprouting HUVEC Networks 
EPCs have been reported to immobilize from a bone marrow compartment and 
respond to angiogenic cues to incorporate into newly-forming angiogenic networks 
(Asahara, et al. 1999). To test whether EPCs have the ability to assemble into networks 
on their own, pEPCs, Human umbilical vein endothelial cells (HUVECs), and porcine 
trophectoderm (pTr2) cells were placed in invasion assays (Bayless, et al. 2009). 
HUVECs, EPCs, and pTr2 cells were labeled with DiI and placed on the surface of 3D 
collagen matrices in the presence of VEGF, bFGF, and S1P for 24 h (Fig 2.5a). Cultures 
were photographed from the side, and HUVEC were able to invade (arrows) below the 
original monolayer (*). EPCs and pTr2 cells, however, had no ability to invade on their 
own under these conditions. Note only a single monolayer has formed with no invading 
structures underneath when EPCs and pTr2 cells are cultured alone. The results were 
similar with HUVEC, EPCs, and pTr cells that were not labeled with DiI (data not 
shown). 
 
 
 
 
 
 
Fig. 2.5a. EPCs have no ability to invade collagen matrices. DiI-labeled HUVECs, EPCs 
or porcine trophectoderm (pTr) cells were seeded as confluent monolayers on the surface 
of collagen gels. Invasion was allowed to proceed for 48 h at which time the gels were 
fixed, stained with DAPI, cut, mounted, and photographed from the side. Arrows 
indicate cells invading beneath the monolayer (*) (width of field = 500 μm). 
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Because EPC incorporation into angiogenic networks in vivo requires adult 
endothelial cells, we next tested whether EPCs can incorporate into sprouting networks. 
To perform these experiments, EPCs (or control pTr2 cells) were placed in sprouting 
assays with HUVEC, which readily form sprouts in the presence of pro-angiogenic 
factors (Fig 2.5a). Unlabeled HUVEC were combined with either EPCs or pTr2 cells 
labeled with DiI so that invasion of both cell types could be monitored (Fig 2.5b). While 
EPCs were able to incorporate into sprouting HUVEC networks (see arrows), pTr2 cells 
had no ability to incorporate and remained on the surface of the collagen matrix as a 
monolayer (*). The results from Figures 2.5a and 2.5b are quantified in Figure 2.6. 
 
 
 
 
 
 
Fig. 2.5b. EPCs, but not pTr2 cells, can incorporate successfully into sprouting 
endothelial networks. Unlabeled HUVECs (40,000) were combined with DiI-labeled 
EPCs or porcine trophectoderm (pTr) cells were placed on the surface of collagen 
matrices in the presence of S1P, VEGF, and bFGF for 48 h. Invasion was allowed to 
proceed for 48 h at which time the gels were fixed, stained with DAPI, cut, mounted, 
and photographed from the side. Arrows indicate cells invading beneath the monolayer 
(*). Note that labeled pTr cells did not invade when seeded onto gels along with 
HUVECs, indicating a selective ability of EPCs to incorporate into HUVEC networks 
(width of field = 500 μm). 
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Fig. 2.6. Quantification of EPC invasion into collagen matrices in the presence and 
absence of HUVEC. The number of DiI labeled invading cells was quantified from 
experiments shown in Figs 2.5a and 2.5b. Four fields from each treatment group were 
used to obtain average number of invading cells per 1mm2 field (+/- SD). Data shown 
are representative of n=4 experiments. 
 
EPC Incorporation into HUVEC Networks is Enhanced by OPN 
The assay system described above (Figs 2.4-2.6) allows us to test the original 
hypothesis that OPN attracts EPCs into sites of active angiogenesis. To perform these 
studies, invasion experiments were established in the presence of pro-angiogenic growth 
factors. HUVEC were placed on the surface of collagen matrices in the presence of DiI 
labeled EPCs to monitor EPC incorporation into sprouting HUVEC networks. In these 
experiments, OPN was added separately to only invading HUVEC, or to HUVECs and 
DiI labeled EPCs in co-culture experiments. While OPN did not affect HUVEC 
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sprouting responses (Fig 2.7, left panel), OPN dose-dependently stimulated EPC 
incorporation into HUVEC networks (Fig 2.7, right panel). 
 
 
 
 
 
 
Fig. 2.7. OPN stimulated increased incorporation of EPCs into sprouting HUVEC 
networks but did not enhance HUVEC invasion. Invasion (48 hr) was stimulated by FGF, 
VEGF, and S1P in all experiments. Left panel: HUVECs were allowed to invade in the 
presence of 0 µg/ml (w/o OPN) or 100µg/ml OPN. Right panel: HUVEC were seeded 
along with DiI labeled EPCs onto collagen gels, and soluble OPN was added to culture 
medium in the bottom chamber at the concentrations indicated. Cultures were fixed, 
stained with DAPI, and the number of invading HUVEC (left panel) and EPCs (right 
panel) was quantified. Four fields from each treatment group were used to obtain 
average number of invading cells per 1 mm2 field (+/- SD). Data shown are 
representative of 4 independent experiments (a and b has statistically significant 
difference, a/b and ab does not). 
 
OPN-stimulated EPC Incorporation Into HUVEC Networks Requires v Integrins  
 The data in Fig. 2.7 indicate that EPCs respond to OPN. Because ITGAV 
expressed on EPCs binds OPN directly (Fig. 2.2b) and ITGAV is required for EPCs to 
attach to OPN (Fig. 2.4b), this raised the question of whether silencing ITGAV in EPCs 
would interfere with OPN-stimulated EPC incorporation into sprouting HUVEC 
networks. To answer this question, HUVECs were co-cultured in invasion assays with 
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control EPCs (no siRNA treatment), or EPCs treated with siRNA directed to ITGAV 
(ITGAV-KD) or GAPDH (GAPDH-KD). In the absence of OPN, the total number of 
invading cells (HUVEC and DiI-labeled EPCs did not change (Fig. 2.8, left panel). 
EPCs lacking ITGAV and GAPDH expression also invaded similarly to Control cells 
(Fig. 2.8, right panel), indicating no role for ITGAV in stimulating EPC incorporation 
into HUVEC networks in the absence of OPN.  
 
 
 
 
 
 
Fig. 2.8. HUVEC and EPC invasion did not change in the absence of OPN. DiI-labeled 
EPCs expressing no siRNA (Control) or siRNA directed to ITGAV (ITGAV-KD) or 
GAPDH (GAPDH-KD) were mixed with unlabeled HUVECs and seeded onto the 
monolayer of collagen gels containing FGF, VEGF and S1P in the absence of OPN for 
48 h before the number of invading cells was quantified. Left panel: Total cell (HUVEC 
and EPC) invasion in the absence OPN. Right panel: EPC invasion in the absence OPN. 
Four fields from each treatment group were used to obtain average number of invading 
cells per 1mm2 field (+/- SD). Data shown represent 4 independent experiments (n=9, 
p=0.09581>0.05).  
 
The data in Fig. 2.8 suggest that OPN engages ITGAV on EPCs to stimulate EPC 
incorporation into sprouting HUVEC networks. To prove this, experiments were 
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* 
conducted as in Figure 2.8 in the presence of OPN. Control EPCs (no siRNA treatment), 
or EPCs treated with siRNA directed to ITGAV (ITGAV-KD) or GAPDH (GAPDH-KD) 
were tested in invasion assays with HUVEC in the presence of 100 µg/ml OPN. In the 
presence of OPN, the total number of invading cells (HUVEC and DiI-labeled EPCs did 
not change (Fig. 2.9, left panel). While EPCs lacking GAPDH expression invaded 
similarly to control cells (Fig. 2.9, right panel), EPCs expressing ITGAV siRNA had a 
decreased ability to incorporate into sprouting HUVEC networks, indicating a 
requirement for ITGAV when EPC incorporation into HUVEC networks was stimulated 
by OPN. Altogether these data suggest that OPN enhanced EPC incorporation into 
sprouting HUVEC networks in a manner that required engagement of ITGAV. 
 
 
 
 
 
 
Fig. 2.9. EPC incorporation into sprouting HUVEC network was enhanced by OPN, but 
HUVEC invasion alone was unaffected. Experiments were conducted as in Fig. 2.8 in 
the presence of 100µg/ml OPN. Di-I labeled EPCs were seeded with HUVECs onto 
collagen gels; soluble OPN was added to culture medium in the bottom chamber at the 
concentrations indicated. Invasion was allowed to proceed for 48 h before the gels were 
fixed with PFA, stained with DAPI, mounted onto slides and the number of invading 
EPCs was quantified (* = P<0.05 or statistically significant difference). 
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Discussion 
During pregnancy, survival and growth of the fetus depends on nutrients that are 
transferred from the maternal to fetal circulation through the placenta. Successful 
pregnancy requires expansion and juxtaposition of the placental and uterine vasculature 
to facilitate exchange of nutrients, gasses and metabolic wastes between mother and 
fetus. Angiogenesis, growth of new blood vessels from the existing vasculature, is 
fundamental to this process. Poor transport of nutrients during development can lead to 
long-term problems throughout adulthood (Findlay 1986, Jaffe 2000, Zygmunt, et al. 
2003). Defective placental and uterine angiogenesis contribute to infertility in several 
gestational pathologies including gestational diabetes, intrauterine growth restriction, 
and preeclampsia, as well as increased life-long cardiovascular risk (Barker 2004, Lain 
and Roberts 2002, Mayhew, et al. 2004, Smith, et al. 2003). In pig placenta, the 
attachment of fetal and maternal epithelium is associated with distinctive changes in 
endometrial epithelial cells, and is strengthened by intertwining of villi from chorionic 
and endometrial epithelial cells and interlocking folds between the two epithelia. Thus, 
nutrient exchange between mother and fetus must penetrate two epithelial layers, and 
successful nutrient transfer is highly dependent on new blood vessel formation. As a 
result, the maternal/fetal interface is a site of rapid and massive blood vessel formation, 
where robust angiogenic blood vessel formation occurs at the interface (Ford, et al. 1982, 
Wu, et al. 2010, Wu, et al. 1995, Zygmunt, et al. 2003).  
Recruitment of EPCs, once known as angioblasts (Kovacic JC 2008), from bone 
marrow to peripheral blood occurs in adults (Zygmunt, et al. 2003). EPCs are an 
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emerging circulating cell type that have been widely studied in cardiovascular medicine 
for their therapeutic potential. However, little is known about EPC numbers and 
functions in either normal or abnormal pregnancies in domestic animals. In humans, 
studies suggested that EPCs may play an important role in the regulation and 
maintenance of the placenta, maintaining vascular integrity during pregnancy (Buemi, et 
al. 2007, Savvidou, et al. 2008, Sugawara, et al. 2005a, Sugawara, et al. 2005b). In this 
study, we find that OPN may aid recruitment of circulating EPC to a developing vascular 
network. Our findings support the upregulation of OPN in areas actively undergoing 
angiogenesis during pig pregnancy since OPN transcript was reported in scattered cells 
of the stratum compactum immediately beneath LE on Day 9 of pregnancy in pigs 
(Garlow, et al. 2002). These studies provide support for the ability of osteopontin to 
increase the incorporation of pEPCs into growing vascular networks. The approach 
utilized a novel in vitro model of endothelial cell invasion characterized by assembly of 
multicellular networks that develop lumens and form angiogenic sprouts (Bayless, et al. 
2009). The pig was found to be a useful source of EPCs, which were isolated in adequate 
numbers from neonates to allow for phenotypic characterization and functional testing in 
sprouting assays, as well as manipulation of gene expression.  
We have isolated and characterized EPCs from the peripheral blood of newborn 
pigs using a hybrid of previously described methods (Asahara 1997). These EPCs 
express integrins, and use these transmembrane receptors to adhere and migrate in vitro 
on osteopontin. Our data indicate the ITGAV subunit expressed on EPCs binds to OPN 
(Fig. 2.3b). ITGAV encodes for the ITGAV subunit (CD51 antigen) of the integrin 
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family, which later forms the vitronectin receptor has a central role in angiogenesis 
(Rüegg and Mariotti 2003). When the function of ITGAV gene is silenced by siRNA, 
ITGAV positive focal adhesions are decreased, as well as other focal adhesion proteins 
including vinculin and paxillin. Vinculin has been implicated in force transmission 
mechanosensing (Dufour, et al. 2013). Paxillin is a signal transduction adaptor protein 
found at the interface between the plasma membrane and the actin cytoskeleton (Turner 
2000). Both vinculin and paxillin regulate force transmission and cell-cell or cell-ECM 
interaction. In this study, EPC binding to bOPN and recombinant RGD decreased with 
ITGAV knockdown, as did the formation of vinculin- and paxillin-positive focal 
adhesions, suggesting the importance of ITGAV in EPC focal adhesion formation and 
interaction with OPN. ITGAV-dependent EPC binding to OPN required the RGD 
domain, as EPCs did not attach to a mutated RAD (Fig. 2.3a. OPN dose-dependently 
increase EPC incorporation in actively invading HUVEC in the three-dimensional 
matrix model, but when ITGAV-silenced EPC were cultured with actively invading 
HUVEC, they fail to invade due to the lack of proper ITGAV to bind to OPN. 
Collectively, these data indicate that OPN promotes attachment and invasion of EPCs 
through ITGAV, enhancing angiogenic responses. 
In conclusion, we offer a novel theory of how placental vascularization may be 
maximized during pregnancy. This includes recruitment of EPCs from the circulation by 
OPN to incorporate into growing vessels. The exact mechanism of the EPC-endothelium 
crosstalk is unknown. Silencing of ITGAV does not completely block EPC incorporation 
into sprouting HUVEC networks, suggesting other mechanisms are involved. Previous 
 58 
 
studies in our lab showed that soluble factors secreted by HUVEC do not stimulate EPC 
invasion (data not shown), strongly suggesting that EPC incorporation into vasculature is 
the result of direct physical communication between EPCs and HUVECs. Since direct 
contact between cell types is required, it is tempting to speculate that junctional 
communication between HUVECs and EPCs may play a role in the crosstalk between 
the two cell types. Adherens, gap, and tight junctions have been shown to play a critical 
role in angiogenic responses (Gärtner, et al. 2012, Wallez and Huber 2008, Wallez, et al. 
2006, Yu, et al. 2011). Thus, one or more of these cell-cell signals may be an important 
component of HUVEC directed EPC incorporation into new vascular networks. Further 
work will be necessary to test whether these pathways are involved in directing EPC 
incorporation into sprouting endothelial networks. Our current incomplete understanding 
of placental and uterine angiogenesis, and the role of EPCs in this process, is a 
formidable barrier to development of new therapies to alleviate or prevent prenatal 
defects. The functional utility of EPCs relies on the availability of an adequate number 
of EPCs with robust ability to home, migrate, and proliferate in target tissues. EPCs 
could become a powerful therapeutic tool because of their mobility and the ability to 
inject intravenously. We hope this study can contribute an understanding of the 
mechanism through which EPC recruitment occurs, and aid the development of novel 
strategies to target diseases in pregnancy associated with dysregulated angiogenesis. 
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CHAPTER III  
EXPRESSION AND REGULATION OF GENES FOR GLUCOSE AND ARGININE 
TRANSPORTERS IN PIG UTERI, CONCEPTUSES AND PLACENTAE 
INCREASES DURING PREGNANCY  
 
Introduction 
Glucose is delivered across cell membranes by either facilitated glucose transport 
(GLUT family uniporters) or sodium-dependent glucose transport (SGLT family 
cotransporters) mechanisms. The two most studied transporter proteins in the SGLT 
family are SGLT1 and SGLT2, which are members of the solute carrier 5A (SLC5A) 
gene family. SGLT1 activity was first discovered in rabbit intestine but expression was 
low (Hediger, et al. 1987). Recent studies have identified glucose transporter SGLT1 
mRNA expression in epithelial cells on the luminal surface of the large intestine, small 
intestine, and stomach in mice (Yoshikawa, et al. 2011). These transporters likely 
provide significant uptake of glucose in the gastrointestinal tract. SGLTs transport 
glucose across cell membranes using a secondary active transport mechanism that 
utilizes a sodium-potassium ATPase pump to deliver glucose and galactose against its 
concentration gradient. This form of glucose transport takes place not only across the 
luminal epithelium, or apical surface of absorptive enterocytes but also in renal proximal 
tubules (Wood and Trayhurn 2007).  
Amino acids are also delivered across cellular membranes using transporter 
proteins. The cationic amino acid transporter proteins are a subfamily of the solute 
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carrier family 7 (SLC7). Four transporter proteins for cationic amino acids have been 
confirmed, including SLC7A1, SLC7A2A, SLC7A2B, and SLC7A3, which can be 
potentially regulated at the transcriptional, mRNA stability, translational and subcellular 
localization levels (Closs, et al. 2007). Cationic or positively charged amino acids are 
transported into the cells for protein synthesis as well as conversion of arginine into NO 
(by NO synthase 2) and polyamines (by arginase) (Fotiadis, et al. 2013). CAT proteins 
were amongst the first mammalian amino acid transporters identified at the molecular 
level and are a major entry path for cationic amino acids in most cells. It is known that 
malfunction of these transporter proteins can affect systemic homoeostasis resulting in a 
number of human diseases. 
The functional significance of sodium-dependent glucose and amino acid 
transporters in the endometrium of the uterus is only beginning to be established. In 
mammals, secretions of the uterine epithelia, called histotroph, are associated with 
conceptus survival and development during the crucial peri-implantation period of 
pregnancy when the conceptus (embryo and associated placental membranes) elongates 
and remains free-floating in the uterine lumen (Bazer 1975). Reports from sheep suggest 
roles for nutrients in conceptus growth and development. Glucose and select amino acids, 
including arginine, leucine, glutamine and glutathione, increase preferentially in the 
uterine luminal fluids of pregnant ewes as compared to the estrous cycle, and there is 
dynamic temporal and spatial expression of SLC7A1, SLC7A2 and SLC5A1 mRNA in 
ovine uterus and placenta during pregnancy (Gao, et al. 2008b). These transporters are 
present in uterine LE and GE, their expression is stimulated by P4 and the expression of 
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SLC7A1 and SLC7A2 is further enhanced by IFNT during early gestation. Importantly 
SLC5A1 is also expressed in the trophectoderm and endoderm of sheep conceptuses 
(Gao, et al. 2008a, Gao, et al. 2009, Gao, et al. 2008b). 
Recently we detected increased glucose and select amino acids in the uterine 
luminal fluids of early pregnant pigs. Further it has been known for some time that there 
is dramatically increased transport of arginine across the placenta in pigs. We 
hypothesized that SLC5A1 expression increases in the endometrium during the peri-
implantation period in pigs and serves as a conduit for the transport of glucose into the 
uterine lumen as a nutrient source for the elongating and implanting conceptus We also 
hypothesized that the increased transport of amino acids, including arginine, across the 
uterine and placental epithelia of pigs is mediated through increased expression of 
cationic amino acid transporters SLC7A1-3. Therefore, we examined the temporal and 
spatial expression of SLC5A1, SLC7A1, SLC7A2 and SLC7A3 at the uterine placental 
interface of pigs as a possible mechanism for increased transport of glucose and arginine 
from mother to fetus during pregnancy in pigs. 
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Materials and Methods 
Experimental Design 
All experimental and surgical procedures were in compliance with the Guide for 
the Care and Use of Agriculture Animals in Research and Teaching and approved by the 
Institutional Animal Care and Use Committee of Texas A&M University. 
 
Study One 
This experiment measured the change in levels of arginine, leucine and glutamine 
within the uterine lumen of cyclic and early pregnant gilts. Gilts were randomly assigned 
to either cyclic or pregnant status. Those in the pregnant group were bred when detected 
in estrus and 12 h later. Gilts were ovariectomized on either days 5, 9, 12 or 15 of the 
estrous cycle or Days 9, 10, 12, 13, 14 or 15 of pregnancy (n=4 gilts per Day per status). 
Uterine horns were flushed with 20 ml of 10 mM Tris buffer (pH 7.0). Pregnancy was 
confirmed by the presence of morphologically normal conceptuses. Uterine flushings 
were purified by centrifugation at 3000 xg for 15 min at 4℃, and the supernatants were 
aliquoted and stored at –80℃ until analysis. 
 
Study Two 
This experiment determined the temporal and spatial expression of SLC5A1 and 
SLC7A1-3 mRNAs in the endometria and conceptuses of cyclic and pregnant gilts. Gilts 
were detected in estrus and assigned randomly for ovariohysterectomy on either Days 
5,9,12 or 15 of the estrous cycle or Days 9, 12, 13, 14, 15, 20, 25, 30, 35 40, 60 or 85 of 
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pregnancy (n=3-4 gilts per Day per status). Conceptuses were collected from Days 12, 
13, 14, and 15 of pregnancy, subjected to fresh 4% paraformaldehyde in PBS (pH 7.2) 
fixation, and embedded in Paraplast-Plus (Oxford Laboratory, ST. Louis, MO). Several 
sections (~0.5 cm) from the middle of each uterine horn were fixed in fresh 4% 
paraformaldehyde in PBS (pH 7.2) and embedded in Paraplast-Plus (Oxford Laboratory, 
St. Louis, MO). The remaining endometrium was physically dissected from the 
myometrium, frozen in liquid nitrogen, and stored at –80°C for RNA extraction. 
 
Study Three 
This experiment determined the effects of short-term treatment with estrogen on 
abundance of SLC5A1 mRNA in the endometria of ovariectomized gilts. Gilts were 
detected in estrus and assigned randomly to receive intramuscular injections daily of 
estradiol benzoate (Sigma, St. Louis, MO) in corn oil (CO) or CO alone (n = 4 gilts per 
treatment) on Days 11, 12, 13, and 14 of the estrous cycle. Gilts were 
ovariohysterectomized on Day 15 of pseudopregnancy, and endometrial tissues collected 
and handled as described in Study 2. 
 
Study Four 
Porcine luminal epithelial (LE) cells were isolated and cultured as previously 
described (Ka, et al. 2007). Passage six LE cells were cultured in DMEM in T25 flasks 
until reaching 60% confluency, and then were treated with β-estradiol 3-benzoate 
(Sigma cat. no. E8515, St. Louis, MO) at 0, 0.05, 0.5, 5, or 50 ng/ml for 24 and 48 h (n = 
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3 flasks per treatment) under an atmosphere of 45% nitrogen, 5% carbon dioxide, and 
50% oxygen. 
 
Analyses of Glucose and Amino Acids in Swine Uterine Flushings 
Uterine flushings (0.5 ml) were deproteinized with an equal volume of 1.5M HClO4 
followed by addition of 0.25 ml of 2 M K2CO3, because they are the preferred acid and 
base, respectively, for processing biological samples for analyses of amino acids (Wu 
and Meininger 2008) and the processed samples also can be analyzed accurately for total 
glutathione (Wang, et al. 2008). Amino acids in the extract were measured by 
fluorometric HPLC methods involving precolumn derivatization with o-
phthaldialdehyde as described previously (Wu, et al. 1997). Total arginine, leucine, 
glutamine were measured as described for cysteine (Wu, et al. 1997). 
The HPLC gradient consisted of mobile phases: A (0.1 mM sodium acetate, pH 7.2) 
and B (methanol) as follows: 0–1 min, 3% B; 1.1–6.5 min, 14% B; 6.6–9.0 min, 100% B; 
and 9.1–16 min, 3% B. The analysis and combination of chromatographic peaks was 
generated in Millenium-32 Software (Waters, Milford, MA).  
 
RNA Isolation Procedure  
Total cellular RNA was isolated from endometrial tissue samples using Trizol 
reagent (Invitrogen, cat. no. 15596-026, Carlsbad, CA) according to manufacturer’s 
recommendations. The quantity and quality of total RNA was determined by 
spectrometry and denaturing agarose gel electrophoresis, respectively. For the in vitro 
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study, RNA from each flask was extracted using an RNeasy Mini kit (Qiagen, cat.no. 
74104, Valencia, CA) following manufacturer’s protocols for amplification and RT-PCR.  
 
In Situ Hybridization Analyses  
Localization of SLC5A1, SLC7A1, SLC7A2, and SLC7A3 mRNAs in sections (5µm) 
of swine uteri was determined by radioactive in situ hybridization analyses as described 
previously (Johnson, et al. 1999b). Radiolabeled antisense or sense cRNA probes were 
generated by in vitro transcription using linearized plasmid template, RNA polymerases, 
and [α-35S]-UTP. Deparaffinized, rehydrated and deproteinated uterine tissue sections 
were hybridized with radiolabeled antisense or sense cRNA probes. After hybridization, 
washing and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic 
emulsion (Kodak, Rochester, NY), and exposed at 4℃ for seven to ten days. Slides were 
developed in Kodak D-19 developer, counterstained with Gill’s hematoxylin (Fisher 
Scientific, Fairlawn, NJ), and then dehydrated through a graded series of alcohol to 
xylene. Coverslips were then affixed with Permount (Fisher Scientific, Fairlawn, NJ). 
Digital images of representative fields were recorded under brightfield or darkfield 
illumination and evaluated using an Axioplan 2 microscope (Carl Zeiss, Thornwood, NY) 
interfaced with an Axioplan HR digital camera and Axiovision 4.3 software. 
Photographic plates were assembled using Adobe Photoshop (version 6.0, Adobe 
Systems Inc., San Jose, CA). 
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RT-PCR and Quantitative PCR Analyses 
Partial mRNAs (3µg) for swine endometrial SLC5A1 and SLC7A3 were amplified 
by RT-PCR using tRNA from endometria collected from uteri of gilts hysterectomized 
on Day 12 and 15 of pregnancy or from placentae of gilts hysterectomized on day 30 of 
pregnancy, respectively. For SLC5A1, the sense primer (5’-taccagcctcttgggctcta-3’) and 
antisense primer (3’- acaaccacccaaatcagagc-5’) were derived from the swine SLC5A1 
mRNA coding sequence. For SLC7A3, the sense primer (5’- cactcaactccatccccact-3’) 
and antisense primer (3’- ctgtggctgtctccagatga-5’) were derived from the porcine 
SLC7A3 mRNA coding sequence (All primers were ordered from Invitrogen, San Diego, 
CA.). Porcine SLC5A1 (152 bp) and swine SLC7A3 (206 bp) products were amplified 
along with the same amount of beta-actin controls using a SuperScript® III Reverse 
Transcriptase Kit (Invitrogen, San Diego, CA). The PCR amplification procedures were : 
1) 95℃ for 2 min; 2) 58C for 30 sec, 50C for 45 sec, and 72C for 1 min for 25 cycles; 
and 3) 72C or 7 min. All samples were loaded in 2% agarose gels containing Bio-Safe 
(Bio-Rad, Hercules, CA) for electrophoresis at 100 V for 1. Images were captured by 
UVP PhotoDoc-It™ Imaging Systems fitted with a Canon A480 digital camera in 
benchtop UV transilluminator (UVP, LLC Upland, CA), followed by densitometry and 
statistical analyses. Quantitative real-time PCR was performed on a Roche LightCycler 
480 real-time PCR system (Roche, USA) with Perfecta SYBR Green Fastmix (Quanta 
Biosciences, Gaithersburg, MD) and 2.5 μM forward/reverse primers to determine 
transcript levels in three replicates (each measured in triplicate). Conditions for cycles 
were as follows: 95°C for 5 min, 40 cycles of 95°C for 10 sec and 60°C for 30 sec. To 
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determine primer efficiency, a relative standard curve was analyzed using a dilution 
series of the appropriate cDNA. Data were analyzed using the comparative Ct method, 
normalized to the endogenous control gene GAPDH (endometrial mRNA) or the 
geometric mean of TBP/SDHA/TUBA1B (placental mRNA). 
 
Measurement of Transport of Arginine by Placenta 
 Arginine transport in pig placentae was determined using L-[U-14C] arginine 
(American Radiolabeled Chemicals (St. Louis, MO) as described previously for 
branched-chain amino acids (Self, et al. 2004).Samples of placentae (∼200 mg) were 
washed three times in oxygenated (95% O2/5% CO2, v/v) Krebs-Henseleit bicarbonate 
(KHB) buffer containing 20 mM HEPES (pH 7.4) and 5 mM glucose. Samples were 
then incubated at 37°C for 5 min in 1 ml of oxygenated KHB buffer consisting of 20 
mM HEPES, 2 mM glutamate, 5 mM glucose, 0.5 or 2 mM arginine, 0.05 μCi L-[U-14C] 
arginine, and 0.05 μCi [3H] inulin (an extracellular marker). After the 5-min incubation, 
the tissues were rinsed thoroughly with fresh KHB buffer and then solubilized in 0.5 ml 
of Soluene 350. The solution was measured for 14C and 3H radioactivities using a dual-
channel counting program in a Packard 1900 liquid scintillation counter (Meriden, CT). 
The specific activity of [14C] arginine in the medium was used to calculate arginine 
uptake by placentae. Results from preliminary experiments established that arginine 
uptake was linear over a 5-min period. 
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Statistical Analyses  
Densitometry analyses were converted by ImageJ (NIH, Bethesda, MD). Data were 
processed in analysis of variance (ANOVA) and student’s T-test. Densitometry values 
were standardized to sample loading control using GraphPad Prism (GraphPad Software, 
San Diego, CA). Partial data are presented with standard errors (SE). Tests of statistical 
significance were generated using the appropriate error terms according to the 
expectation of mean squares. Statistical analyses for qPCR were run using a one-way 
ANOVA with Tukey’s test for mean comparison. 
 
Results 
Glucose and Amino Acids in Uterine Flushings 
Glucose increased in the uterine flushings from both cyclic and pregnant gilts 
between Days 10 and 13 (P<0.05) (Fig. 3.1). Glucose was not different in uterine 
flushings from cyclic and pregnant gilts (P>0.05).   
 
 
 
 
Fig. 3.1. Glucose increased in uterine flushings of cyclic and pregnant gilts.  
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Arginine was increased in the uterine flushings of Day 15 pregnant over Day 15 
cyclic gilts (P<0.05) (Fig. 3.2). No differences in the quantity of leucine and glutamine 
were detected within the uterine flushings of cyclic and pregnant gilts (P>0.05) (Fig. 3.2). 
 
 Fig. 3.2. Arg, Leu and Glu in uterine flushings of cyclic and pregnant gilts. 
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SLC5A1 mRNA Expression in Uteri and Placentae 
In situ hybridization localized SLC5A1 mRNA to the endometrial LE and GE of 
both cyclic and pregnant gilts (Fig. 3.3). SLC5A1 was induced in both the LE and GE of 
both cyclic and pregnant gilts between Days 5 and 9, and then decreased in these cell 
types between Days 9 and 12 of the estrous cycle (Fig. 3.3). In contrast to the estrous 
cycle, SLC5A1 mRNA further increased in the LE between Days 9 and 12 and mRNA 
reached maximal levels in LE by Day 13 (Fig. 3.3). SLC5A1 then decreased to 
background levels in all cell types (both endometrial and placental) between Days 13 
and 14 of gestation (Fig. 3.3). RT-PCR and qPCR confirmed that SLC5A1 mRNA levels 
are higher in the endometrium of Day 12 pregnant over Day 12 cyclic gilts (Fig. 3.4). 
 
Fig. 3.3. In situ hybridization for SLC5A1 expression in the endometria of cyclic and 
pregnant gilts. SLC5A1 mRNA increases initially in the luminal epithelium (LE) and GE 
of both cyclic and pregnant gilts, but mRNA expression further increases in the LE of 
pregnant gilts by Day 12. 
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Fig. 3.4. RT-PCR and qPCR for SLC5A1 mRNA in endometrium of Day 12 cyclic and 
pregnant gilts. Steady state levels of SLC5A1 mRNA are greater in the endometria of 
Day 12 pregnant over cyclic gilts (Normalization factor for rt-PCR is beta-actin and for 
qPCR is GAPDH) (* = P<0.05 or statistically significant difference). 
 
Estrogen Upregulates SLC5A1 Expression in Endometrium 
In situ hybridization localized SLC5A1 mRNA to the endometrial LE of Day 15 
pseudopregnant gilts suggesting estrogen specifically induces expression of SLC5A1 
mRNA in the LE (Fig. 3.5). In agreement with in situ hybridization data, steady state 
levels of SLC5A1 mRNA as measured by RT-PCR and qPCR increased in the 
endometrium of estrogen-treated (pseudopregnant) over CO-treated cyclic gilts (Fig. 3.6). 
Treatment of cultured porcine LE cells confirmed that estrogen can directly increase the 
SLC5A1 transcription in the LE (Fig. 3.7). 
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Fig. 3.5. In situ hybridization for SLC5A1 mRNA in the endometria of Day 15 cyclic 
(CO) and pseudopregnant (E2) gilts. Estrogen induces expression of SLC5A1 mRNA in 
the LE of pseudopregnant gilts. 
 
 
 
 
 
 
Fig. 3.6. RT-PCR and qPCR for SLC5A1 mRNA in the endometria of Day 15 cyclic and 
pseudopregnant gilts. Steady state levels of SLC5A1 mRNA are greater in endometria of 
pseudopregnant over cyclic gilts (Normalization factor for rt-PCR is beta-actin and for 
qPCR is GAPDH) (* = P<0.05 or statistically significant difference) 
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Fig. 3.7. RT-PCR and qPCR for the in vitro expression of SLC5A1 mRNA in porcine 
endometrial LE cells treated with estrogen. Estrogen dose-dependently increased the 
expression of SLC5A1 mRNA in porcine LE cells (Normalization factor for rt-PCR is 
beta-actin and for qPCR is GAPDH) (a and b has statistically significant difference or 
p<0.05). 
 
Amino Acid Transporter SLC7A3 Increase in Later Pregnancy in Gilts 
In situ hybridization of cationic amino acid transporter SLC7A3 mRNA shows 
that SLC7A3 mRNA expression increases in the trophoblast/chorion between Days 20 
and 25 then reaches maximal levels by Day 30 (Fig. 3.7). No expression of SLC7A1 and 
SLC7A2 were detected. Strong expression of SLC7A3 persists in areolae and interareolar 
region through Day 85 of pregnancy (Fig 3.8). SLC7A3 mRNA increases in placentae 
between Days 30 and 60 of pregnancy (P<0.05) (Fig 3.9). No significant difference in 
the arginine transport was found between areolae and inter-areolae area across the 
placentae of pregnant gilts (P>0.05) (Fig 3.10).  
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Fig. 3.8. In situ hybridization for SLC7A3 expression in the placentae of gilts. SLC7A3 
mRNA increases in trophoblast/chorion between Days 20 and 25, increases to maximal 
levels by Day 30, and high expression of SLC7A3 is maintained in areolae and 
interareolar trophoblast/chorion through Day 85 of pregnancy. 
 
 
 
 
 
 
Fig. 3.9. RT-PCR and qPCR results for SLC 7A3 mRNA in placenta of Day 30 and Day 
60 pregnant gilts. SLC7A3 mRNA increases in placentae between Days 30 and 60 of 
pregnancy (Normalization factor for rt-PCR is beta-actin and for qPCR is geometric 
mean of TBP/SDHA/TUBA1B) (* = P<0.05 or statistically significant difference). 
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Fig. 3.10. Arginine transport in areolae and inter-areolae area across the placentae of 
Day 60 pregnant gilts. No significant difference in the transport of arginine was found 
between areolae and inter-areolae across the placentae of Day 60 pregnant gilts (P>0.05). 
 
Discussion 
Pig implantation and placentation are different from that in sheep because porcine 
have an epitheliochorial placenta in which uterine luminal epithelium is superficial but 
remain intact throughout pregnancy. Pig trophectoderm attaches to the luminal 
epithelium and serves as the platform for maternal hematotrophic and histotrophic 
nutrient support for conceptus growth (Björkman 1973, Corner 1921). Pig implantation 
is a fascinating model to investigate and placentation-associated gene regulation is very 
unique. Estrogen is secreted by pig conceptuses between Days 10 and 15 for pregnancy 
recognition, which redirects prostaglandin F2 secretion from an endocrine (toward 
uterine vasculature) to an exocrine (toward the uterine lumen) pattern and later 
metabolized to prevent luteolysis of the corpus luteum (Bazer 1983). The importance of 
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estrogen in pig pregnancy has been studied extensively. E2 increase expression of 
numerous genes within the uterine LE such as FGF7, AKR1B1, IRF2, MX1, EDG7, 
NMB, B2M and CD24 to enhance proliferation, migration, adhesion and gene expression 
that supports implantation and conceptus development (Bazer, et al. 2012b)  
The importance of glucose and amino acid in pigs has been underscored previously. 
Arginine supplement to the diet of pregnant gilts between days 30 and 114 of pregnancy 
significantly increased litter birth-weight and the number of live-born piglets (Wu, et al. 
2007). In this study, we measure the glucose levels in uterine flushing in gilts and found 
the transitory increase at day 12 of pregnant gilts. The level of glucose in uterine 
flushings could not be explained by facilitated glucose transporter expressions patterns 
such as SLC2A1-3 (unpublished results by Johnson et al.). We hypothesized that sodium 
dependent glucose transporter SLC5A1 plays an important role in this sudden increase in 
the uterine flushings. Since this is also a critical time period in swine pregnancy when 
estrogen, the pregnancy recognition signal is secreted, may regulate the expression of 
this gene. A pseudopregnant model was utilized for in situ hybridization. SLC5A1 
expression was remarkably higher in the estrogen-treated gilts. An in vitro experiment 
also shows expression of SLC5A1 increases dose-dependently with estrogen treatment. 
The arginine family of amino acid plays an important role in swine reproduction 
and promote nutrient metabolism, such as glucose synthesis because arginine, glutamine, 
glutamate, proline, aspartate, asparagine, ornithine, and citrulline are interconvertible via 
complex interorgan metabolism (Wu and Meininger 2002). The cationic amino acid 
transporters (CATs) comprise the SLC7 family and SLC7A1-3 are known plasma 
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membrane transporters that accept arginine as a substrate (Closs, et al. 2004). Arginine 
plays a key role in placental angiogenesis and growth in mammals; andarginine 
provision enhances reproductive performance of gilts (Mateo, et al. 2007). The temporal 
and spatial expression of cationic amino acid transporter SLC7A1 was demonstrated in 
this study. Our in situ hybridization results suggests that SLC7A1 mRNA expression 
significantly increases from Day 30 to Day 60 in the trophoblast/chorion through Day 85 
of pregnancy and support an interpretation that SLC7A1 plays a key role in carrying 
essential amino acid across the placentae to maintain nutrients transport and support fetal 
growth in mid to late pregnancy in gilts. This increase in the SLC7A3 expression 
corresponds with previous data published by Wu et al. showing the increase transport of 
arginine in pigs (Wu, et al. 1995). No significant difference in the transport of arginine 
was found between areolae and inter-areolae across the placentae of Day 60 pregnant 
gilts. Paracellular transport may be upregulated at this time due to the change in 
expression pattern of tight junction proteins including claudins (unpublished results by 
Johnson et al.). 
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CHAPTER IV 
CONCLUSIONS 
 
Nutrients provided by the maternal and placental vasculatures during healthy 
pregnancy, including glucose and amino acids, are known to play a critical role in 
optimizing embryonic growth and regulating fetal development (Bloomfield, et al. 
2013a). Uterine nutrients are supplied via the uterine vasculature and in pigs that have 
true epitheliochorial placentation, nutrient are transported across the uterine luminal 
epithelium (LE) and placental chorion to gain access to the placental allantoic 
vasculature that serves to transport these nutrients, rich in sugars, amino acids, proteins 
and electrolytes to the fetus (Bazer, et al. 2012a, Wu, et al. 2010). 
Placental development is highly dependent on the growth of new blood vessels 
(neovascularization) during pregnancy in all forms of placentation including 
hemochorial placentation in humans, mice, and rats, endotheliochorial placentation in 
most carnivores such as cats and dogs, synepitheliochorial placentation in ruminants 
such as sheep and cows, and epitheliochorial placentation of pigs, horses, camels and 
whales. One important cell type involved in the neoangiogenesis is the endothelial EPC 
which originates from the bone marrow and enters the systemic circulation for 
distribution to sites of neoangionenesis. This monocytic cell has the ability to 
differentiate into endothelial cells and contribute to vascular sprouting. 
OPN, a matricellular protein that is highly upregulated during pregnancy, is 
abundantly expressed in the extracellular matrices of the uterine and placental stroma of 
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pigs (Garlow, et al. 2002, White, et al. 2005). This expression is highly correlated to 
sites of angiogenesis. Many characteristics of OPN and EPCs are complimentary to each 
other: (1) EPCs express integrins while OPN binds to integrins; (2) EPCs home to sites 
of inflammation while OPN is upregulated during inflammation; (3) EPCs differentiate 
into endothelial cells while OPN is an endothelial cell chemoattractant; (4) EPCs are 
involved in pathologic angiogenesis while OPN is upregulated in these pathology; and (5) 
EPCs, increase during healthy pregnancy while OPN is highly upregulated during 
gestation (Apte, et al. 2005, Asahara 1997, Asou, et al. 2001, Bailey, et al. 2010, Buemi, 
et al. 2007, Caiado and Dias 2012, Denhardt and Guo 1993, Duvall, et al. 2007, Erikson, 
et al. 2009, Garlow, et al. 2002, Gomer 2008, Hristov, et al. 2003, Matsubara, et al. 2006, 
White, et al. 2005). The relationship between EPCs and OPN in uterine and placental 
tissues has not been previously investigated.  
The first part of this thesis identified and determined the physiological pathways 
that promote vascular growth within the placenta in vitro. Porcine EPCs were isolated 
from newborn piglets and propagated in culture for more than 30 passages with stocks of 
cells frozen back at each passage. These EPCs developed an endothelial-like phenotype 
in culture as endothelial cell markers increased while monocyte markers decreased with 
increasing passage. EPCs express integrins including ITGAV, and use these 
transmembrane receptors to adhere and migrate in vitro on osteopontin. An innovative 
three-dimensional collagen matrix model supplemented with potent angiogenesis 
promoting S1P was used to explore functional characteristics of EPCs, and their surface 
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markers, that allow EPCs to form angiogenic networks in three-dimensions and 
incorporate into vascular networks. 
A novel discovery in this investigation was that OPN increased recruitment of 
circulating EPC to a developing vascular network. When EPCs were cultured alone as a 
monolayer on the surface of 3D collagen matrices supplemented with angiogenic factors, 
they failed to invade the matrix; however, when cultured with HUVECs, which invade 
the matrix and form vascular structures, the EPCs incorporate into these vascular 
structures, similar to their role in vivo. Furthermore, the number of EPCs that invaded 
the matrix increased in a dose-dependent manner in the presence of OPN. 
 OPN contains several functional domains including binding sites for ITGAV (the 
(Caiado and Dias 2012, Casals, et al. 2010). Porcine EPCs were shown to express the 
ITGAV which has been shown to bind OPN (Fig. 2.2b, Fig. 2.3a). Silencing the function 
of the ITGAV gene by siRNA decreased the ability of EPCs to bind OPN and decreased 
ITGAV-associated focal adhesions including the focal adhesion vinculin and paxillin 
involved in transducing force between cells and the ECM necessary to promote invasion. 
ITGAV silencing also blocked the ability to incorporate into actively invading HUVECs. 
These investigations have allowed the development of a novel theory of how placental 
vascularization maximizes during pregnancy. This includes recruitment of EPCs from 
the circulation by OPN and their incorporation into growing vessels. 
 The specific junctional proteins responsible for the EPC-HUVEC crosstalk 
remain to be determined. Adherens, gap, and tight junctions play a crucial role in 
angiogenic responses (Gärtner, et al. 2012, Wallez and Huber 2008, Wallez, et al. 2006, 
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Yu, et al. 2011) and may be involved in HUVEC directed EPC incorporation into 
angiogenic network. Based upon previous studies that suggest that soluble factors 
secreted by HUVECs do not stimulate EPC invasion and therefore the mechanisms 
involving EPC incorporation into vasculature are expected to be a result of direct 
physical communication between EPCs and HUVECs. Immediate future studies will 
investigate the role of junctional communication between HUVECs and EPCs. Specific 
endothelial cadherins, occludins and gap junctions proteins have been selected in future 
studies as targets for knockdown experiments. 
While our understanding of placental and uterine angiogenesis, and the role of 
EPCs in this process, is incomplete and presents a barrier to development of new 
therapies to alleviated or prevent prenatal defects. EPCs could become a powerful 
therapeutic tool because of its mobility, differential potential and possibility to inject 
intravenously. These investigations contribute to a more mechanistic understanding of 
the behavior of EPCs and may contribute to the development of novel strategies 
targeting diseases in pregnancy associated with dysregulated angiogenesis.  
In pigs, glucose can be transported from both sides of placenta. Two families of 
cellular glucose transporters have been identified: the facilitated-diffusion glucose 
transporters (GLUT) and the sodium-dependent glucose transporters (SGLT). Many 
glucose transporters and most amino acid transporters belong to the solute carrier family 
(SLC). The SGLTs, which includes SLC5A and cationic amino acid transporters, which 
belongs to the SLC7 family, are known to be expressed in mammalian species (Bell, et al. 
1990, Fotiadis, et al. 2013, Gao, et al. 2012). However, while glucose and amino acid 
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transporter expression patterns have been identified in some species, the regulated 
expression glucose and amino acid transporters in uterine and placental tissues during 
pregnancy has not been fully established in pigs.  
The second part of this thesis determined temporal and spatial cell-specific 
changes in expression of SLC5A1 and SLC7A3 in porcine conceptus and uteri during the 
estrous cycle and during the peri-implantation period of pregnancy and the effect of 
estrogen on their expression in the uterus. Glucose and amino acid (arginine) transport 
level increased in uterine flushings in pregnant over cyclic gilts at the periimplantation 
period. Notably, the increase in glucose level at day 12 in pregnancy gilts correlated with 
upregulated SLC5A1 expression in quantitative PCR analysis. The mechanism for this 
upregulation was shown to involve estrogen, the pregnancy recognition signal in pigs, 
based upon in vivo and in vitro experiments. These studies also provide new insights for 
the basis of the observation that arginine levels increase in the placenta during late 
pregnancy in the pig. The increase in arginine correlated with the expression of a major 
cationic amino acid transporter, SLC7A3, which increased later pregnancy in gilts.  
This investigation provides new insights into the expression pattern and 
regulation of glucose and amino acid transporters in porcine pregnancy. It is hoped that 
this fundamental knowledge can provide a more comprehensive knowledge of nutrient 
transport to the fetus that may be useful in the development of clinical strategies to 
reduce infertility and prevent pregnancy loss in domestic livestock where the majority of 
embryonic loss occurs primarily at peri-implantation period of early pregnancy (Wilmut, 
et al. 1986, Wu, et al. 2010). 
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